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ABSTRACT 
 
The presynaptic serotonin (5-HT) transporter (SERT) is targeted by widely 
prescribed antidepressant medications. Altered SERT expression or regulation has been 
implicated in multiple neuropsychiatric disorders, including anxiety, depression and 
autism. It has been previous reported that SERT is regulated by lipid raft, a cholesterol-
enriched subdomain  in the plasma membrane that has been frequently reported a 
platform to facilitate neuronal signaling. 
To better understand the membrane diffusion dynamics of SERT, I developed a 
single quantum dot (QDot) tracking approach that exploits antagonist-conjugated single 
QDots to monitor, for the first time, single SERT proteins on the surface of serotonergic 
cells. We document two pools of SERT proteins defined by lateral mobility, one that 
exhibits relatively free diffusion, and a second, localized to cholesterol and GM1 
ganglioside-enriched microdomains, that displays restricted mobility. Receptor-linked 
signaling pathways that enhance SERT activity mobilize transporters that, nonetheless, 
remain confined to membrane microdomains. Mobilization of transporters arises from a 
p38 MAPK-dependent untethering of the SERT C terminus from the juxtamembrane 
actin cytoskeleton. Our studies establish the utility of single QDot tracking approach for 
analysis of the behavior of single membrane proteins and reveal a physical basis for 
signaling-mediated SERT regulation. 
In line with the single QDot-SERT analysis, single QDot-labeled ganglioside GM1 
was incorporated in this dissertation that aimed to quantitatively measure the diffusion 
dynamics and membrane compartmentalization of lipid raft in living RN46A cells. 
Diffusion measurements revealed that single QDot-labeled GM1 ganglioside complexes 
undergo slow, confined lateral diffusion with a diffusion coefficient of 7.87 × 10–2 μm2/s 
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and a confinement domain about 200 nm in size. Further analysis of their trajectories 
showed lateral confinement persisting on the order of tens of seconds, comparable to 
the time scales of the majority of cellular signaling and biological reactions. Hence, our 
results provide further evidence in support of the putative function of lipid rafts as 
signaling platforms. 
Finally, I discussed the recent progress of single-QDot techniques, with 
emphasis on their applications in exploring membrane dynamics and intracellular 
trafficking. In recent years, single QDot imaging approach has been introduced as a sub-
category of single molecule fluorescent techniques for revealing the single 
protein/vehicle dynamics in real-time. One of the major advantages of using single 
QDots is the high signal-to-noise ratio, which is beneficial due to the unique 
photophysical properties of QDot such as extraordinarily high molar extinction 
coefficients and large Stokes shifts. Although there are some limitations due to the 
physical nature of the QDots, advances in QDot synthesis and surface chemistry show 
significant potential to eliminate these pitfalls. Considering the applications of a single 
QDot approach in the past few years, I am optimistic that the use of single QDots in 
bioimaging will largely advance our understanding in the biological research field in the 
near future. 
  
vii 
 
 
TABLE OF CONTENTS 
 Page 
DEDICATION ................................................................................................................. iii 
ACKNOWLEDGEMENTS .............................................................................................. iv 
ABSTRACT ……………………………………………………………………………………. v 
LIST OF TABLES ............................................................................................................ xi 
LIST OF FIGURES ......................................................................................................... xii 
 
Chapter 
1 SINGLE-QUANTUM DOT IMAGING FOR MOLECULAR NEUROSCIENCE  ….. 2 
1.1 Introduction ............................................................................................................ 2 
1.2 Water-Soluble Quantum Dot for Biological Labeling ............................................. 4 
1.3 Overview of Single-Quantum Dot tracking ............................................................ 9 
1.4 Recent Advances of Single-Quantum Dot Tracking in Neuroscience Research .. 13 
1.5 Summary ............................................................................................................... 15 
1.6 Reference .............................................................................................................. 17 
 
2 SINGLE QUANTUM DOT IMAGING TECHNIQUES (METHODS) ...................... 22 
2.1 Microscopy Setup for QDot-Based Single-Molecule Observation ........................ 22 
2.2 Imaging Data Processing and Subpixel Localization ........................................... 25 
2.3 Diffusion Theory and Calculation ......................................................................... 28 
2.4 Imaging System Calibration Using Spin-Cast Single Quantum Dots ................... 32 
2.5 Single Quantum Dot Labeling in Living Cells ....................................................... 34 
2.6 Tracking Programs for Single-Molecule/Quantum Dot Analysis .......................... 36 
2.7 References ........................................................................................................... 42 
viii 
 
 
3 PROBING MEMBRANE DYNAMICS OF LIPID RAFTS WITH SINGLE-QUANTUM 
DOT IMAGING ..................................................................................................... 45 
3.1 Introduction .......................................................................................................... 45 
3.2 Material and Methods .......................................................................................... 46 
3.2.1 Single QDot Labeling of Ganglioside GM1 in RN46A cells .................................. 46 
3.2.2 Microscopy ........................................................................................................... 46 
3.2.3 Subpixel Localization and Trajectory Generation ................................................. 47 
3.2.4 Instantaneous Velocity ......................................................................................... 48 
3.2.5 Diffusion Coefficients and Membrane Confinement ............................................. 48 
3.3 Results .................................................................................................................. 50 
3.3.1 Instrument response and single-molecule sensitivity inspection .......................... 50 
3.3.2 Basal membrane diffusion in living RN46A Cells ................................................. 52 
3.3.3 Single quantum dot tracking of lipid raft constituent ganglioside GM1 ................. 54 
3.3 Summary .............................................................................................................. 59 
3.4 References ........................................................................................................... 62 
 
4 SINGLE MOLECULE ANALYSIS OF SEROTONIN TRANSPORTER 
REGULATION USING ANTAGONIST-CONJUGATED QUANTUM DOTS …….. 65 
4.1 Introduction ........................................................................................................... 65 
4.2 Materials and Methods ......................................................................................... 67 
4.2.1 Cell Culture, Treatments, and SERT Activity Assay ............................................. 67 
4.2.2 Labeling RN46A Cells with Ligand-Conjugated Quantum Dots ........................... 68 
4.2.3 Microscopy ........................................................................................................... 69 
4.2.4 Data Analysis of Single Quantum Dot Imaging .................................................... 69 
4.3 Results ................................................................................................................. 70 
4.3.1 Single Molecule Analysis of QDot-labeled SERT Reveals a Membrane 
Microdomain-Associated Subpopulation of Transporters With Confined Diffusion 70 
ix 
 
4.3.2 Single QDot-Labeled SERT Proteins Demonstrate Increased SERT Lateral 
Mobility, Despite a Confined Distribution, after 8-Br-cGMP Treatment …………. 78 
4.3.3 The p38 MAPK Inhibitor SB203580 Attenuates 8-Br-cGMP Induced Enhancements 
in SERT Lateral Mobility ...................................................................................... 80 
4.3.4 IL-1β Activated Single SERT Proteins Reveal p38 MAPK-Dependent 
Subpopulation ...................................................................................................... 81 
4.3.5 Cytoskeletal Disruption Mobilizes SERT Molecules That Remain Confined to 
Membrane Microdomains .................................................................................... 84 
4.4 Discussion ........................................................................................................... 89 
4.5 References ......................................................................................................... 94 
 
5 SUMMARY AND FUTURE PERSPECTIVE ....................................................... 98 
5.1 Introduction ........................................................................................................ 98 
5.2 Mapping Receptor Membrane Diffusion ............................................................ 102 
5.3 Endosomal Trafficking and Endocytosis ............................................................ 105 
5.4 Dynamic Processes of Intracellular Targets ....................................................... 107 
5.5 Single-Quantum Dot FRET ................................................................................ 110 
5.6 3-D Single Quantum Dot Tracking ..................................................................... 112 
5.7 Conclusion and Future Perspective ................................................................... 114 
5.8 References ......................................................................................................... 116 
 
Appendix  
A QUANTUM DOT DISPLACEMENT ASSAY FOR ANTIDEPRESSANT DRUG 
SCREENING ...................................................................................................... 120 
A.1 Abstract .............................................................................................................. 120 
A.2 Introduction ........................................................................................................ 121 
A.3 Experimental Section ......................................................................................... 123 
A.3.1 IDT318 ligand synthesis .................................................................................... 123 
x 
 
A.3.2 hSERT-expressing oocyte prepapation ............................................................. 123 
A.3.3 Quantum dot-hSERT labeling and displacement in oocytes .............................. 124 
A.3.4 Microscopy ......................................................................................................... 125 
A.3.5 Two-electrode voltage-clamp electrophysiological analysis .............................. 126 
A.3.6 Data Analysis ..................................................................................................... 126 
A.4 Results ............................................................................................................... 129 
A.5 Discussion ......................................................................................................... 137 
A.6 References ........................................................................................................ 138 
  
xi 
 
LIST OF TABLES 
 
Table 1.1  Recent quantum dot applications in the studies of neuronal receptors and 
transporters ................................................................................................................... 16 
 
  
xii 
 
LIST OF FIGURES 
 
Figure 1.1  Basic properties of fluorescent quantum dot .............................................  5 
Figure 1.2  Three general strategies to yield water-soluble QDots. ............................ 6 
Figure 1.3  Covalent coupling strategies of amino and carboxyl functionalized QDots  8 
Figure 1.4  Schematic representation of the diffraction pattern from a point emitter 
passed through an optical device ............................................................ 11 
Figure 1.5  Approach to single-QDot microscopy ........................................................ 12 
 
Figure 2.1 Quantum efficiency of a Back-Illuminated EMCCD camera ...................... 23 
Figure 2.2 Schematic of 2D Gaussian regression of a singleQDot fluorescent image 26 
Figure 2.3  Schematic of a step displacement plot of single-molecule tracking ……... 27 
Figure 2.4  Schematics of different modes of diffusive behavior .................................  30 
Figure 2.5  A typical intensity over time plot from a single blinking QDot ...................  33 
Figure 2.6  Example live-cell imaging of membrane proteins labeled with single 
QDots …………………………………………………………………………... 35 
Figure 2.7  Snapshot of the interface of Matlab-based particle tracking program 
originally developed from particle tracking using IDL algorithm ………....  37 
Figure 2.8  Steps of single QDot tracking using ParticleTracker - an ImageJ plugin   41 
 
Figure 3.1  Schematic of the optical setup of the line-scanning confocal microscope.  50 
Figure 3.2  Visualization of single QDots on a glass support ………………………….  51 
Figure 3.3  Trajectories and instantaneous velocity of AMP QDots non-specifically 
bound to the plasma membrane of living RN46A cells …………………...  53 
Figure 3.4  Membrane diffusion of AMP QDots shows a non-directional random walk 54 
Figure 3.5  Trajectories and instantaneous velocity of single QDot-conjugated GM1 
complexes in the plasma membrane of living RN46A cells ……………....  55 
Figure 3.6  Comparison of diffusion behavior of single AMP QDots and QDot-labeled 
GM1 complexes in the RN46A cells ………………………………………..  57 
xiii 
 
Figure 3.7  Spatiotemporal 3D representation of movement of the single QDot-GM1 
complexes in living RN46A cells …………………………………………….  58 
 
Figure 4.1  Tracking of QDot-labeled single SERT proteins …………………………..  74 
Figure 4.2  Single QDot-SERT tracking in living serotonergic RN46A cells under control 
and MCD-treated conditions ……………………………………………….  75 
Figure 4.3  Single QDot-labeled SERT proteins demonstrate elevated SERT lateral 
mobility after membrane raft disruption …………………………………….  76 
Figure 4.4  Characterization of the dynamic behavior of single SERT proteins …….  77 
Figure 4.5  Effect of 8-Br-cGMP on SERT lateral mobility …………………………….  79 
Figure 4.6 p38 MAPK-dependent increase in SERT mobility in the absence of lateral 
dispersion …………………………………………………………………….. 83 
Figure 4.7  Cytoskeletal disruption mobilizes SERT molecules that remain confined to 
membrane microdomains ………………………………………………….... 86 
Figure 4.8  Actin cytoskeleton restricts SERT mobility within membrane microdomains 
in a p38 MAPK and SERT C-terminus dependent manner …………….... 87 
Figure 4.9  Dissociation of SERT C-terminus from cytoskeletal-associated proteins 
creates increases in single SERT diffusion and SERT transport activity  88 
Figure 4.10  Model for SERT-cytoskeletal interactions dictating cell surface transporter 
regulation ……………………………………………………………………...  93 
 
Figure 5.1  Schematic representation of the diffraction pattern from a point emitter 
passed through an optical device ………………………………………….. 101 
Figure 5.2 Single QDot-SERT tracking in living serotonergic RN46A cells under control 
and lipid raft-disrupted conditions ………………………………………….. 104 
Figure 5.3 Single QDotimaging for endosomal trafficking and endocytosis ……….. 106 
Figure 5.4 Characterization of nucleocytoplasmic transport with single QDot 
approach …………………………………………………………………….... 109 
Figure 5.5 Single QDot-FRET for DNA detection ……………………………………... 111 
Figure 5.6 3-D single QDot tracking with DH-PSF imaging approach …………….... 113 
 
xiv 
 
Figure A.1  Schematic of IDT318 synthesis …………………………………………….  123 
Figure A.2  Schematic of putative two-stage ligand-SERT dissociation mechanism of 
QDot-labeled ligand-SERT complexes in the oocyte expression system 128 
Figure A.3  Fluorescence displacement assay based on ligand-conjugated QDots for 
antidepressant drug discovery ……………………………………………..  129 
Figure A.4  Target-selective QDot-SERT labeling via IDT318 ……………………….  130 
Figure A.5  (A) Current response induced by IDT318 ligand incubation. B) Comparison 
of current responses with QD labeling results for the indication of alkyl 
space participated in ligand binding ……………………………………….  132 
Figure A.6  IC50 measurement of IDT318 ligand ……………………………………….  134 
Figure A.7  Displacement analysis of the QDot-ligand labeled hSERT with 
paroxetine…………………………………………………………………….. 135 
Figure A.8  Displacement of the IDT318 conjugated QD with 10 M paroxetine and     
5-HT …………………………………………………………………………..  136 
1 
 
The majority part of chapter 1 was published as a review (Chang, J.C., Kovtun, 
O., Blakely, R.D. & Rosenthal S.J. (2012) Labeling of neuronal receptors and 
transporters with quantum dots. WIREs: Nanomedicine and Nanobiotechnology, 
4, 605–619) by Wiley Periodicals, Inc., and some part of this chapter was 
published by Cell Press (Rosenthal, S.J., Chang, J.C., Kovtun, O., McBride, J.R. 
& Tomlinson, I.D. (2011) Biocompatible quantum dots for biological applications. 
Chemistry & Biology, 18, 10-24). Permission is granted for the author’s request 
for the dissertation use and for the benefit of the author's institution. 
 
 
 
All other uses, reproduction and distribution, including without limitation 
commercial reprints, selling or licensing copies or access, or posting on open 
internet sites, your personal or institution’s website or repository, without 
permission from the publisher are prohibited.  
 
  
2 
 
CHAPTER 1 
 
SINGLE-QUANTUM DOT IMAGING FOR MOLECULAR NEUROSCIENCE 
 
1.1 Introduction 
Since the pioneering neuroanatomical work of Santiago Ramón y Cajal in the 
early 20th century, the need to visualize dynamic communication within neuronal 
networks has been a challenge for modern neuroscience.1 Synaptic transmission, and 
hence central nervous system (CNS) excitability, are modulated in a tightly regulated 
manner by a myriad of neuronal membrane receptors and transporters that rely on 
specific ligand binding and transport and the initiation of intracellular signaling cascades. 
Despite extensive biochemical and genetic analyses, mechanisms that regulate synaptic 
receptor and transporter activity, trafficking, and localization continue to challenge 
neuroscientists.2, 3 These considerations have driven our desire to combine recently 
developed receptor and transporter labeling methods with the tools of advanced 
fluorescence imaging that can permit single molecule visualization to dissect 
mechanisms of synaptic protein trafficking and signaling.  
Fluorescent labeling techniques commonly used to interrogate cellular processes 
can be classified into two broad categories: (1) the construction and expression of 
fluorescent fusion proteins such as GFP4, 5 and (2) chemical methods of fluorescent 
labeling.6 With the rapid evolution of fluorescent protein technology and the elaboration 
of readily available, multicolor GFP expression vectors, GFP-based labeling methods 
have quickly found widespread use as the proteins produced bypass many time-
consuming probe preparation steps and assure that labeling is restricted to specifically-
tagged proteins. However, certain limitations are associated with the GFP fusion 
approach: (1) The inability of GFP construct transfection to provide for the study 
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endogenously expressed proteins; (2) The failure of GFP-tagged proteins to, in some 
cases, localize properly; (3) Differences in the activity and signaling of GFP-tagged 
proteins compared to their wild-type counterparts. As a result, fluorescence labeling 
strategies have emerged as important alternatives for the visualization of cellular 
proteins, particularly those that prove incompatible with GFP-based methods. However, 
since chemical labeling techniques typically utilize conventional fluorescent dyes, live-
cell imaging is often hampered by the low photostability and brightness, narrow Stoke’s 
shift, and relatively broad emission spectra of these labels. To address these 
shortcomings, researchers have developed fluorescent nanomaterials with significantly 
improved optical properties for biological imaging. 
Semiconductor nanocrystals, also known as quantum dots (QDots) are one such 
class of fluorescent nanomaterials that overcome instability issues associated with 
conventional fluorescent dyes.7-9  Over the past decade, QDots have shown tremendous 
potential for in vitro and in vivo biological imaging.8-12  Among the capabilities QDots offer 
to the life science research,serving as a bright and stable fluorescent tag for 
singlemolecule imaging is perhaps the most exciting one. No this note, an interesting 
property associated with QDots is the fluorescent intermittency, known as 
blinking,whereby a time trace of fluorescent intensity from a single QDot can switch 
between two distinct on/off states.13 This blinking phenomenon is sometimes considered 
a minor drawback since it might cause temporary trajectory data loss in single-molecule 
tracking.14 On the other hand, blinking is often used to identify single molecules, 
providing a practical benefit.15, 16 Details of single QDot tracking and its recent advances 
in the neuroscience field are discussed later in this chapter. 
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1.2 Water-Soluble Quantum Dot for Biological Labeling 
As crystalline inorganic nanoparticles, QDots are typically composed by 
semiconductor materials, such as CdSe or CdTe. Because of their inherent quantum 
confinement effect with discrete atomic-like energy levels, QDots are often described as 
‘artificial atoms’. By adjusting their size, the emission spectra of QDots can be tuned to 
cover the entire visible range (Fig. 2). The quantum yield of QDots can be significantly 
improved after capping the “core” with a wider bandgap semiconductor “shell”. Until now, 
the most commonly used and most well-known QDot architecture is the CdSe/ZnS 
core/shell QDot.17, 18 Typically, QDots are synthesized in organic solvents at high 
temperatures and passivated with hydrophobic surfactants such as trioctylphosphine 
oxide (TOPO) and trioctylphosphine (TOP) to yield monodisperse and stable particles.7 
However, these surfactant-passivated QDots require hydrophilic functionalization prior to 
any further biological application. In 1998, two groups simultaneously reported different 
procedures for designing water-soluble QDots which lead to a new era of QDots in 
biological applications. The first approach, originally demonstrated by Alivisatos and 
coworkers,9  involves a hydrophilic silica shell around quantum dot. In this procedure, 
functional organosilicone molecules are directly absorbed onto the QDot surface. As 
QDots are embedded into a highly cross-linked silica shell, these coated CdSe QDots 
are extremely stable with 6-15% quantum yield. The second approach, initially reported 
by Chen and Nie,8 employs a ligand exchange strategy to displace the hydrophobic 
surfactant on the QDot surface with thiol (−SH) functionalized hydrophilic ligand. 
However, water-soluble QDots produced by the above approaches tend to cause 
aggregation, absorb nonspecifically, and yield lower quantum efficiency.19 In order to 
overcome these shortcomings, a breakthrough approach reported by Dubertret et al. 
utilizes bifunctional hydrophobic/hydrophilic phospholipids to self-assemble onto the 
hydrophobic QDot surface, forming a water-soluble micelle while retaining the organic 
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surfactants on the QDot surface.20 This elegant approach was subsequently improved by 
several groups using ampiphilic copolymer.21, 22 As the organic surfactant is retained, the 
inherent photophysical properties are preserved to the highest extent. The micelle 
encapsulation strategy is generally superior to surface silanisation or ligand exchange 
approach in generating water-soluble QDots with better photostability and lower 
toxicity.22  The schematic of common methodologies used in water-soluble QDot 
preparation is shown in Figure 1.2.Notably, two major commercial QDot suppliers, 
Evident Technologies and Invitrogen, have all adapted micelle encapsulation approach 
for their water-soluble QDot product line. 
 
 
Figure 1.1 Basic properties of fluorescent quantum dot. (A) Diagram of surfactant-
passivated quantum dot. (B) Absorption and emission spectra of CdSe quantum dots 
with different core sizes. (C) Photograph of CdSe QDots under UV illumination illustrates 
that QDot emission can be tuned across the visible spectrum. (D) High resolution atomic 
number contrast scanning transmission electron (Z-STEM) micrograph shows the atomic 
structure of individual CdSe QDots. 
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Figure 1.2 Three general strategies to yield water-soluble QDots. (A) Silica-shelled 
water-soluble QDots is generated by replacing TOPO ligand with functional 
organosilicone molecules containing thiol group. (A) TOPO ligand on QDot surface is 
replaced by wate-soluble mercaptocarbonic acids via ligand-exchange approach. (C) A 
water-soluble QDot micelle is formed by encapsulating a TOPO QDot with amphilphilic 
polymer. 
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 Although the ampiphilic copolymer-encapsulated QDots (AMP QDots) are 
disperse and remain stable in an aqueous solution, the polymershells easily cause non-
specific binding to the cell membrane,23 most likely due to the hydrophobic interaciton 
between the polymer and the lipid bilayer.24In a pioneer work reported by Bentzen et al., 
six different cell types, HEp-2, LLC, HEK, COS7, 3T3, and CHO were tested to verify the 
nonspecifically staining of unconjugated AMP QDots to these cell lines. Importantly, the 
authors concluded that the degree of nonspecific staining of AMP QDots to different cell 
lines are not uniform, in which the HEK cells was the highest among the list. To resolved 
this shortcoming, the author functionalized AMP QDots with poly(ethylene glycol) 
(PEG)and the non-specific labeling was significantly reduced.23 
 The ability to detect specific targets in biological studies relies on linking QDots to 
bioaffinity ligands, such as antibodies, peptides, oligonucleotides, saccharides, or small-
molecule drugs. Three general types of strategies used in attaching bioaffinity ligands 
onto the QDot surface are: (1) covalent conjugation, (2) streptavidin-biotin assembly, 
and (3) electrostatic interaction. In the first approach, water-soluble QDots synthesized 
with carboxyl functionalized surface enable the conjugation of amino terminated ligands 
via EDC coupling strategy (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide; EDC)23 (Fig. 
1.3A). However, in certain cases where (i) site-specific controlled coupling is required, or 
(ii) to avoid random polymerization of QDot-ligand complexes if the chosen ligand 
contains multiple amines, an alternative method for site-specific conjugation can be 
achieved for coupling thiol terminated bioaffinity ligands with amino surface 
functionalized QDots via SMCC heterobifunctional crosslinker (Succinimidyl-4-(N-
maleimidomethyl) cyclohexane-1-carboxylate: SMCC) (Fig. 1.3B). Both amine and 
carboxyl terminated water-soluble QDots are commercially available from Invitrogen. 
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Figure 1.3 Covalent coupling strategies of amino and carboxyl functionalized QDots. (A) 
EDC coupling of ligand with free amine group to carboxyl terminated water-soulble QDot. 
(B) Covalent coupling of thiol terminated ligand to amino terminated water-soluble QDot 
via SMCC bi-functional cross-linker. 
 
In addition to covalent coupling methodology, non-covalent binding approaches 
such as streptavidin-biotin assembly strategy are also commonly used in QDot 
nanoprobe design. Streptavidin- functionalized QDots (SA-QDots), which take 
advantage of the strong streptavidin-biotin non-covalent interaction (Kd: ~10-14), were 
initially designed for immunofluorescent labeling with a biotinylated antibody.25 Since 
their introduction, SA-QDots are commonly used due to the fact that a wide variety of 
commercially available biotinylated molecules, such as peptides, proteins, and 
antibodies, have already been routinely applied in various biological experiments.26, 27 
Additionally, SA-QDots appear to have no effect on random association of endogenous 
proteins, permitting target-specific labeling in living cells.28 
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An alternative non-covalent coupling strategy involves electrostatic interaction, 
where the biomolecules are engineered with positively charged domains that can self-
assemble onto the negatively charged, functionalized QDot surface. Such an approach 
was pioneered by Mattoussi et al.29  which showed that electrostatic forces can be used 
to drive self-assembly between the dihydrolipoic acid (DHLA) capped CdSe/ZnS QDots 
and engineered maltose binding proteins (MBP) bearing a positively charged binding 
domain. Recently, Clapp et al.30  provided a detailed protocol which allows the 
electrostatic coupling method to be applied to any protein appended with either an 
electrostatic attachment domain (namely, the basic leucine zipper) or a polyhistidine 
(poly-His) tag. 
 
1.3 Overview of Single-QuantumDotTracking 
 Single-molecule fluorescent microscopy, derived from high-speed fluorescence 
microscopy, is probably the most accessible method for cell biologists to investigate 
single-molecule dynamics in living cells.31  The basis of this method is to follow the real-
time movement of individual molecules by using fluorescent microscope, resulting in a 
map of the dynamics upon observing many individual events. Based on the above 
definition, a high sensitivity is required that allows individual single molecules to be 
monitored in a picoliter to femtoliter-sized microscope sampling volume. However, even 
if performed on an optimally designed microscope, equipped with a camera offering 
single photon sensitivity per frame, optical detection of a single molecule is still 
diffraction-limited. The diffraction pattern of a point object viewed through a microscope, 
known as the Airy disk, is illustrated in Figure 1.4 and can be modeled by an appropriate 
point-spread function (PSF). The theoretical 2D paraxial PSF of the wide field 
fluorescence microscope can be calculated as:32 
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21( )[2 ]em
em
J k NA rPSF
k NA r
      [1] 
where r is the radial distance to the optical axis, NA is the numerical aperture, J1 is the 
first-order Bessel function, ݇௘௠ ൌ ଶగ  defines the emission wavenumber, and  is the 
wavelength of light. The smallest resolvable distance between two points of the 2D plane 
corresponds to the first root of the PSF and is given by the Rayleigh distances 33, 
0.61Rxyd NA
  [2] 
As can be seen from the eq. [1] & [2], under the important prerequisite in which single 
emitters are placed in extremely low concentration to be spatially separated greater than 
the diffraction-limited region, it is possible to identify the localization (x, y) of a single 
molecule from an optical microscope image by fitting the PSF. Indeed, the fundamental 
idea of the modern single-molecule microscopy is reliant on PSF fitting to localize the 
centroid position of single point emitters. As a result, the achievable accuracy and 
precision of the fitted position is highly dependent upon the signal-to-noise ratio (SNR).It 
is important to note that organic fluorescent dyes suffer from limited photon yield and 
narrow Stokes shift (difference in excitation and emission wavelength). These 
drawbacks make them difficult to produce a sufficient SNR and can increase background 
signals which further reduce SNR. Hence, the shortcomings associated with organic 
fluorophores places a high demand for advanced materials such as QDots for single-
molecule tracking. 
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Figure 1.4 Schematic representation of the diffraction pattern from a point emitter 
passed through an optical device. Owing to diffraction, the smallest distance to which an 
imaging system can optically resolve separate light sources at is limited by the size of 
the Airy disk. 
 
The process of QDot-based single-molecule microscopy is typically divided into 
three steps (Fig. 1.5). The first step is to acquire time-lapse imaging after single target-
specific labeling has been made. Single fluorescent molecules should be able to 
produce diffraction-limited blurred spots in each flame. The second step involves 
imaging data processing and single-molecule localization from time-lapse images and is 
therefore normally anticipated as a computationally demanding step. In the third step, 
the diffusion dynamics can be analyzed from the trajectories of individual molecules, e.g. 
Brownian motion. Each step will be discussed in detail in Chapter 2. 
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Figure 1.5 Approach to single-QDot microscopy. (A) Time-lapse images of single QDot-
tagged biomolecules in living cells acquired from an optical fluorescent microscope 
system. (B) Estimation of the positions of single QDots with sub-pixel accuracy and 
trajectory generation. (C) Analysis of diffusional properties (displacement, velocity, and 
diffusion coefficient) from single-QDot trajectories. 
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1.4 Recent Advances of Single-Quantum Dot Tracking in Neuroscience 
Research 
Dahan and coworkers first reported the diffusion dynamics of endogenous 
glycine receptor (GlyR) in living neurons using single QDot tacking technique.34  The 
specific detection of GlyR α1 subunits was achieved through the use of a primary 
monoclonal antibody, a biotinylated Fab fragment of the secondary antibody, and Sav-
QDots. This pioneering study made it possible to reveal multiple diffusion domains of 
glycine receptors in synaptic, perisynaptic, and extrasynaptic locations. 
In 2008, Lévi et al. established that Ca2+-driven excitatory synaptic transmission 
significantly restricted GlyR lateral diffusion and led to an increased subsequent 
clustering of GlyRs within the synaptic domain.35 A following experiment reported by 
Charrier et al. in 2010 demonstrated that such a regulation of GlyR lateral diffusion at the 
excitatory synapses is mediated by β1 and β3 integrins, cell adhesion molecules and 
signaling receptors that interact via calcium/calmodulin-dependent protein kinase II.36 
This progression is an impressive example of the evolution of QDots as fluorescent 
probes aimed at unraveling the molecular aspects of neuronal receptor regulation.  
A similar “sandwich” approach was also employed by Bouzigues et al.37  to label 
GABAARs in the tips of growing axons, the growth cones (GCs), of the rat spinal cord 
neurons. In the presence of an extracellular GABA gradient, the authors showed that 
single QDot-labeled GABAA receptors redistribute asymmetrically across the growth 
cone, located at the axon tip, toward the gradient source in a microtubule- and calcium-
dependent manner. In 2009, Bannai et al.38  relied on a modified approach for GABAAR 
labeling, in which a biotinylated secondary Fab fragment was used in conjunction with 
primary antibody and Sav-QDots. In this study, the authors demonstrated that GABAAR 
diffusion coefficient and confinement domain size increase in response to enhanced 
excitatory synaptic activity. 
14 
 
A distinct labeling approach based on Streptavidin-biotin assembly was 
developed in the Ting Lab, where the authors adapted an enzymatic reaction to 
specifically biotinylate their proteins of interest.39 In their design, a fifteen amino acid 
acceptor peptide sequence (AP) is genetically fused to a C- or N-terminus of the protein, 
and a bacterial enzyme biotin ligase (BirA) is used to biotinylate a lysine side chain 
within the AP sequence. Howarth et al. applied this approach to label AP-fused α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors in hippocampal neurons 
and then study AMPA receptor synaptic localization.40 
Cui and colleagues also used the biotin-Streptavidin approach to prepare QDot 
nanoconjugates to label nerve growth factor (NGF) receptors in live PC12 and rat dorsal 
root ganglion (DRG) neurons.26 In their study, biotinylated NGF peptides were pre-
conjugated to Sav-QDots with a stoichiometric ratio of NGF to QDot of 1 to 1.2 to 
achieve a monovalent presentation of NGF dimer on the QDot surface. In a clever setup, 
NGF-QDot conjugates were first added to the microfluidic chamber containing distal 
axons of DRG neurons and allowed to bind and form complexes with NGF receptors and 
undergo subsequent internalization into early endosomes. Endosomes containing NGF-
QDots were then demonstrated to exhibit “stop-and-go” retrograde transport toward the 
neuronal cell body with an average speed of 1.31 ± 0.03 µm/s. Similarly to Cui et al.,26 
Fichter and coworkers employed the preconjugation strategy to link a biotinylated anti-
hemagglutinin (HA) antibody to SA-QDot. The resulting QDot conjugates were used to 
label HA-fused serotonin receptor subtype 1A (5-HT1A) and investigate the kinetics of 
receptor-mediated internalization of QDots.41 
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1.5 Summary 
In the past two decades, technological advances in QDot synthesis have 
advanced opportunities for fluorescence-based biological imaging.42 Currently available 
QDot probes are characterized by minimal cytoxicity, improved stability in biological 
environments, and ultra-low non-specific binding. Most importantly, advances in surface 
chemistry have allowed for the preservation of key QDot optical properties, including 
high quantum yield, large Stokes shift, and narrow fluorescence emission spectra. These 
advances have prompted a significant increase in the use of QDots by molecular and 
cellular neuroscientists. An exhaustive list of the recent instances of QDots used to 
target neuronal receptors and receptors is given in Table 1.1. 
The most important achievement of QDot nanotechnology for molecular 
neuroscience is likely to be the single QDot tracking approach to investigate diffusion 
dynamics of membrane proteins at the single-molecule level. We mentioned previously 
that Dahan and coworkers were first to utilize this tool to interrogate the lateral diffusion 
of individual glycine receptors.34 Similar approaches were subsequently employed to 
investigate various neuronal signaling related targets including nerve growth factor 
(NGF),26 glial fibrillary acidic protein,43 and gamma-aminobutyric acid A receptor 
(GABAAR).38 To fully explore the tremendous potential that QDots offer to the field of 
neuroscience, interdisciplinary collaborations of researchers representing a diverse 
range of disciplines, including chemistry, material science, neuroscience, pharmacology, 
and medicine, are required. With the continuous advances in QDot synthesis in parallel 
with the improvements in the QDot bioconjugation protocols, hopefully it will not be long 
before QDot-based biological labeling technique is considered as a routine method in a 
standard neuroscience laboratory. 
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Protein of interest Targeting 
probe 
QDot conjugation 
strategy 
Cellular expression model Reference 
Serotonin transporter Organic ligand Ligand exchange Transfected HEK293 cells 11 
Serotonin transporter Organic ligand Biotin-Sav binding mRNA-microinjected 
Xenopus 
44 
Serotonin transporter Organic ligand Biotin-Sav binding Serotonergic RN46A cells 45 
Dopamine 
transporter 
Organic ligand Biotin-Sav binding Transfected flp-In 293 cells 46,47 
GABAc receptor Organic ligand EDC coupling mRNA-microinjected 
Xenopus oocytes 
48 
GABAA receptor 
(with GFP tag) 
Anti-GFP 
antibody 
2nd antibody coupled 
to QDot 
Hippocampal neurons 49 
Glycine receptor Antibody Biotin-Sav binding Primary rat spinal cord 
neurons 
34, 35 
Glycine receptor Antibody SPDP/SMCC 
coupling 
Transfected HeLa cells, 
primary neurons 
50 
Glial fibrillary acidic 
protein 
Antibody Biotin-Sav binding Primary neurons and glia 43 
TrkA and and P75 
NGF receptors 
NGF peptide Biotin-Sav binding PC12 cells 51, 52 
5-HT1A receptor (with 
HA tag) 
Anti-HA 
antibody 
Biotin-Sav binding N2a cells 41 
AMPA receptor Antibody 2nd antibody coupled 
to QDot 
Primary rat cortical neurons 36, 53 
AMPA receptor Peptide 2nd antibody coupled 
to QDot 
Primary rat hippocampal 
neurons 
40 
Cannabinoid type 1 
receptor 
Antibody 2nd antibody coupled 
to QDot 
Primary rat hippocampal 
neurons 
54 
NMDA receptor Antibody 2nd antibody coupled 
to QDot 
Primary rat hippocampal 
neurons 
55 
metabotropic 
glutamate receptors 
(mGluR5) 
Antibody Biotin-Sav binding Primary rat hippocampal 
neurons 
56 
Nicotinic 
acetylcholine 
receptor (nAChR) 
Protein/toxin Biotin-Sav binding Neuromuscular synapses in 
the mouse diaphragm 
57 
Nicotinic 
acetylcholine 
receptor (nAChR) 
Antibody; 
Protein/toxin 
Biotin-Sav binding Chick CG neurons 58 
Angiotensin II 
receptor type 1 
Peptide EDC coupling Transfected CHO cells  59 
Presynaptic L-type 
calcium channel 
Antibody Biotin-Sav binding Synapses of the tiger 
salamander retina 
60 
P2 purinergic 
receptors 
Organic ligand EDC coupling PC12 cells 61 
D2 dopamine 
receptor 
Organic ligand EDC coupling Transfected A9 cells 62 
 
Table 1.1 Recent quantum dot applications in the studies of neuronal receptors and 
transporters 
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CHAPTER 2 
 
SINGLE QUANTUM DOT IMAGING TECHNIQUES (METHODS) 
 
2.1 Microscopy Setup for QDot-Based Single-Molecule Observation 
 Driven from high-speed video microscopy, single-molecule tracking has been 
demonstrated in various configurations of fluorescent microscopes, including wide-field 
epifluorescence, confocal, and total internal reflection fluorescence (TIRF) microscope. 
The basic requirements for single-molecule microscopy are: a high numerical aperture 
(NA) objective, dichroic and emission filters, a stable monochromatic excitation source, 
and an ultrasensitive photon detector, combined with appropriate software for imaging 
acquisition and data processing. However, real-time visualization of fluorescent signal 
from a single-molecule is not an easy task. In principle, the microscope system needs to 
be optimized to maximize the number of detected photons while still guaranteeing 
minimizing any background noise. 
 A standard wide-field epifluorescence microscope equipped with an ultrasensitive 
photon detector is by far the simplest microscopy setup for single-molecule tracking. 
Taking advantage of high quantum yield of core/shell QDots, common excitation light 
source, such as a mercury or a xenon arc lamp, may be sufficient;1 however, laser 
illumination, which provides higher power and narrower excitation wavelength, is a better 
(although more expensive) choice. As noted in Chapter 1, single-molecule microscopy is 
a technique highly dependent on SNR. To achieve ultra-sensitivity with high temporal 
resolution, detector for fluorescent imaging is required to obtain high quantum efficiency 
with minimum shot-noise. A commonly used detector for single-molecule imaging is the 
electron-multiplying charge-coupled device (EMCCD). Back-illuminated type EMCCD 
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cameras are preferred due to their better quantum efficiency (~90%) in the visible region 
(Fig. 2.1).1, 2 
 
Figure 2.1 Quantumefficiency of a Back-Illuminated EMCCD camera. (iXon DV 887 
EMCCD; Andor Technology, Belfast, Northern Ireland) (adapted from AndorCCD 
specification documents at http://www.andor.com). Noted the high 
quantumefficiency(Evolve > 90% across the 500 – 650 nm visible spectrum), this can 
serve to reduce the exposure time for greater temporal resolution for single molecule 
imaging. 
 
 In addition to the detector, there are other factors that impact the SNR. In a wide-
field epifluorescence microscope, the excitation bean passes through the entire 
specimen and may excite any fluorophores in the illumination path, including molecules 
outside the focal plane, which increases background noise. A solution to overcome this 
drawback is TIRF microscopy.3 For a typical biological sample in aqueous buffer, TIRF is 
particularly useful since the difference in refractive index, n, between water and a glass 
cover-slip is large enough to generate total internal reflection for TIRF microscopy 
imaging (water n=1.33; cover-slip n=1.52). Currently, TIRF microscopy is the most 
popular setup for QDot-based single-molecule tracking.2, 4, 5 
 Conventional point scanning confocal microscopy, which effectively excludes the 
out-of-focus fluorescence by adding an additional pinhole, is capable of generating an 
image with high positional accuracy. However, this approach suffers from low temporal 
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resolution and is seldom used in single-molecule tracking, even though it provides an 
advantage without the restriction of imaging close to the proximity of an interface like 
TIRF. For example, the Zeiss LSM 510 META is a popular point-scanning confocal 
microscope. In a high noise fast scanning setup, data collection takes about 1-2 seconds 
to acquire a 512  512 pixels image. As a result, the acquisition of a single frame with 
high SNR may take more than 5 seconds. Recently, two advanced confocal microscope 
configurations, distinguished by their scanning approaches, have been introduced for 
their rapid scanning speeds. The first approach named as the spinning-disk confocal 
method (SDCM) uses a disc with a series of pinhole apertures to process simultaneous 
multi-spot scanning.6 The second method is often referred to as the line scanning 
confocal method (LSCM), which uses an oscillating mirror to simultaneously illuminate 
an entire line of the specimen and focus the fluorescence into a linear detector.7 
Currently, confocal systems based on these fast scanning concepts to achieve video 
frame rates suitable for single-molecule imaging are commercially available, which 
include the LSCM microscope by Carl Zeiss (LSM 7 Live: 120 frames/sec @ 512x512 
pixels), SDCM microscope by Leica (SD6000: multipoint scanning at 1000 Hz), and 
SDCM microscope by Andor (custom-made system: 30 frames/sec @ 512x512 pixels). 
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2.2 Imaging Data Processing and Subpixel Localization 
 As we described in the introduction, fluorescent intensity distribution from a 
single emitter can be fit with a 2D Gaussian.8, 9 To calculate a subpixel estimate of single 
QDot position, the general method is to fit the single QDot intensity distribution with a 2D 
Gaussian function and then calculate the local maximum intensity (Fig. 2.2): 
2 2
0 0
2
( ) ( )
0
x x y y
w
xyI A A e
      [3] 
where Ixy is the intensity of the pixel, x0 and y0 is the designated local maximum 
coordinates of the Gaussian, A is the amplitude of the signal with local background A0, 
and w is the width of the Gaussian curve. The smallest distance at which two emitters 
can be recognized and separated is roughly equal to the full width at half maximum 
(FWHM) of the w : 
ln(4) 1.177FWHMw w w    [4] 
It is important to note that the coordinate (x0 , y0) acquired by fitting function [3] 
using chi-squared minimization is not a true position, but only an estimate. The accuracy, 
as we mentioned in the introduction, is strongly dependent upon the respective SNR, 
which is defined as:9 
0
0
2 2
bg I
ISNR     [5] 
where I0 is the maximum signal intensity above background, ߪ௕௚ଶ  is the variance of the 
background intensity values, and ߪூబଶ  is the true variance of the maximum signal intensity 
above the background. Since w width is approximately equal to the wide-field diffraction 
limit (for visible light is about 250 nm), the uncertainty of the fitted coordinate (Δ) is 
approximately given by: 
250 ( )nm
SNR
   [6] 
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Figure 2.2 Schematic of 2D Gaussian regression of a single QDot fluorescent image. 
Note that a much more accurate localization in the center can be obtained by fitting the 
2D Gaussian function to the experimental intensity data 
 
After x and y coordinates of the targeted single-molecules are determined in 
each frame, cumulative displacement of each single targets can be generated to reflect 
the rate of movement (Fig. 2.3). The timecourse of the corresponding moment is 
determined by the following formula: 
 [ ( ) ( )] [ ( ) ( )] (1/2)2 2nd = x n + 1 - x n + y n + 1 - y n  [7] 
where x(n), y(n) denotes the position in frame (n), dn indicates that a single step 
takes place during a single lag time t from time point t(n) to t(n+1). 
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Figure 2.3 Schematic of a step displacement plot of single-molecule tracking. 
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2.3 Diffusion Theory and Calculation 
 Simple diffusion caused by the random movement of molecules is known as 
Brownian motion. The general diffusion theory of Brownian motion was developed by 
Einstein in 190510 and is still suitable to describe single-molecule protein dynamics. 
Importantly, according to Einstein’s theory, the diffusion coefficient, D, is not dependent 
on the velocity, but is essentially determined by the mean square displacement (MSD). 
In his paper entitled “On the movement of small particles suspended in stationary liquids 
required by the molecular-kinetic theory of heat”,10 Einstein started with a 1D random 
walk. Assuming that a total of n Brownian particles move only along a given axis, x, in a 
time interval, τ, where the displacement of individual particle is Δ, the equations Einstein 
obtained reads: 
( )dn n d    [8] 
where ( ) 1d


   , and   satisfies the condition ( ) ( )     
From the condition of the function ( )  , he then calculated the distributions of the 
particle at (t + ) from their distribution at time t:  
( , ) ( ) ( )f x t dx dx f x d        [9] 
Based on the equation [7] and [8], an equation for the diffusion coefficient Dcan be 
derived from the MSD 2 : 
2
21 1( )
2 2
D d 


      [10] 
In a 2D and 3D random walk case, equation [10] can be rewritten as: 
2D:  2 4     [11] 
3D:  2 6     [12] 
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From the equation [10], Einstein shows how the diffusion coefficient can be 
related to the MSD in single-molecule dynamics. However, the diffusion process may not 
follow Brownian motion in many biological systems. Common causes include diffusion 
barriers in the cellular structures, active transport along intracellular networks, or 
membrane-facilitated exocytotic and endocytotic processes. For the cases of non-
Brownian motion in the biological systems, it is very difficult to obtain an explicit solution. 
Methods for connecting MSD estimates with motion modes can roughly be classified into 
“itemized” and “unified”. The former type of method classifies the diffusion modes into 
several categories. Each mode has a distinct 2  vs. time dependence, such as that 
studied by the Saxton and Jacobson 11 for the lateral diffusion modeling of individual 
proteins or lipids in the plasma membrane. Listed below are the models proposed by 
Saxton used for predicting diffusion processes in biological systems (Fig. 2.2). 
2 4     ---normal diffusion  [13] 
2 4     ---anomalous diffusion [14] 
2 24 ( )      ---directed motion with diffusion [15] 
2
2
4
2 2
1[1 ]
c
A D
r
cr A e

    ---corralled motion [16] 
, where D denotes the diffusion coefficient, is the time-resolution,  is the anomalous 
diffusion exponent,  is the velocity, 2cr  indicates the corral size, and A1 and A2 are 
constants determined by the corral geometry. 
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Figure 2.4 Schematics of different modes of diffusive behavior. (A) and their 
corresponding MSD plot (B). When MSD is plotted as a function of time, the linear plot of 
MSD versus time represents normal diffusion. When the change in MSD is nonlinear 
with time, an increasing slope indicates directed diffusion, and confined diffusion 
(anomalous diffusion or corralled motion) produces an MSD plot with a decreasing slope. 
 
Due to its simplicity and ability to produce rapid results, the random walk model 
(normal diffusion) is commonly used to estimate the diffusion coefficient. However, in 
biological interpretation, anomalous diffusion was reported as the dominant model of 
diffusion dynamics in the plasma membrane.12, 13 The standard method to obtain the 
diffusion coefficient from anomalous diffusion model is through a linear fit, as indicated 
below, since this fit converges more consistently than the variable power-law fit:12 
    2log log log 4D      [17] 
 In a complicated biological environment, diffusion mode of the same biological 
target may vary at different time scales. For example, it has been reported that G-protein 
coupled receptor (GPCR) shows a confined diffusion mode at the short time scale, 
indicating entrapment at certain membrane compartment. However, at the longer time 
scale GPCRs can move from onecompartment to another, undergoing free diffusion.14 
This phenomenon is often referred to as “hop diffusion”. In complicated cases like this 
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one, using a “unified” method in which only one simple equation is used to fit the MSD 
data over the entire time scale seems to be a better approach. Therefore, Destainville 
and Salomé proposed to use a simple law to fit MSD data.15 A single equation is 
provided with two time-correlation functions: a short-term diffusion coefficient Dµ 
describes a rapid, “microscopic” diffusion behavior, and a long-term diffusion coefficient 
DM indicates a slower, “macroscopic” movement: 
2 1 exp( ) 4
3 M
L D
T
         , and 
2
12
LT
D
 , [18] 
whereL is the typical size of the short-term confining domains and T is the so-called 
“equilibration” or “relaxation” time. As a result, the size of the shot-term confinement 
zone (L2) can be estimated.  
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2.4 Imaging System Calibration Using Spin-Cast Single Quantum Dots 
A general strategy to identify whether the optical system is able to detect 
individual QDots is to carry out time-lapse imaging of a very dilute QDot solution to avoid 
multiple QDots overlapping within diffraction limited distance. Individual QDots are 
characterized by their blinking properties. The emission intensity of a single QDot is 
shown in Figure2.3, where a single QDot blinks completely on and off during a time-
lapse sequence of 80 sec at a 10 Hz frame rate. When the fluorescence is produced by 
an aggregate structure consisting of several QDots, such blinking effects are completely 
cancelled out. The protocol described below is based on a custom-built Zeiss Axiovert 
200M inverted fluorescence microscope coupled with a charge-coupled device (CCD) 
camera (Cool-SnapHQ2, Roper Scientific, Trenton, NJ). To track single QDots in real-time, 
the acquisition rate should be set at 10 Hz or higher. However, the imaging rate is 
usually limited by the frame readout time of the camera. This particular CCD is chosen 
due to its adequate 60 % quantum efficiency (QE) throughout the entire visible spectrum 
range (450 - 650 mm) with a frame rate > 20 at 512  512 pixels (see Photometrics CCD 
specification document at http://www.photomet.com). And again, as introduced in the 
section 2.1, a more advanced back-illuminated Electron Multiplying CCD (EMCCD) with 
sub-msec temporal resolution will be a much better choice. Imaging should be 
performed with a high-resolution (63 or 100) oil-immersion objective lens with 
numerical aperture of 1.30 or greater. 
The sample preparation steps are: 
1.  Prepare a clean microscope glass slide coverslip or 35 mm culture dish with a 
coverslip at the bottom (e.g. MatTek dish). 
2.  Add 1 drop (20 μL) of 100 pM QDot 605 ITK™ carboxyl quantum dots 
solution onto the coverslip. 
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3.  Spin cast the QDot solution on the coverslip for 30 sec at 2000 rpm or less. 
(Note: The spinning force is not critical in this step. In most cases, a rotational 
speed as low as 500 rpm is sufficient to achieve a uniform spread when using 
common compact spin coater.) 
4.  Mount the coverslip on the microscope stage. 
5.  QDots are excited using a xenon arc lamp (excitation filter 480/40 BP) and 
detected with CCD camera thorough appropriate emission filter (600/40 BP 
for QDot 605). Acquire time-lapse images (100 msec per frame, 60 sec). 
 
 
Figure 2.5 A typical intensity over time plot from a single blinking QDot. As displayed in 
the left panel, the intensity trajectory of a single QDot displays two dominant states: an 
“on” state and an “off” state, termed blinking. A predefined intensity threshold is shown 
by the dashed line. Right panel displays the probability density distribution. 
34 
 
2.5 Single Quantum Dot Labeling in Living Cells 
Single quantum dot labeling can be prepared through either a direct labeling (one 
step) procedure or an indirect (two step) protocol. In the direct labeling procedure, the 
target-specific probe (small molecule organic ligand, peptide, or antibody) is directly 
conjugated to the QDots surface to make ligand-QDot nanoconjugates. Therefore, the 
cellular labeling strategy could be performed in one step in which the live cell sample is 
incubated with a target-specific nanoconjugate prior to fluorescent imaging. In the two 
step procedure, the cell sample is first incubated with biotinylated ligand to yield the 
desired specific ligand-protein binding. After an appropriate washing step, strep-QDots 
are added as the fluorescent tag of the biotinylated ligand-protein complex for the single-
molecule imaging. 
A general protocol for single QDot labeling of adherent cells is given here, which 
is applicable to most mammalian cell lines. The standard protocol given below should be 
followed: 
1. Prepare a 35 mm coverslip-buttoned culture dish with cells that have reached 
about 50 % confluence. 
2. Wash the cells gently 3 times with Phenol red-free culture medium by repeatedly 
pipetting out. 
3. Incubate cells with a biotinylated small molecule probe (0.5 nM- 0.5 µM dependent 
upon the biological affinity) or antibody (1-10 µg/mL) in red-free DMEM for 20 min 
at 37 °C. (For one step labeling protocol, incubate cells with 10-50 pM ligand-
QDot nanoconjugates and skip step 4-5) 
 Note: The labeling concentration/cell type relationship should be adjusted for the 
surface protein expression level. In our experiments, we choose low 
concentrations for transfected cells. For labeling endogenously expressing 
membrane proteins in living cells, higher concentrations may be needed. 
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4. Wash cells gently 3 times with Phenol red-free culture medium. 
5. Incubate the cells with QDot Streptavidin conjugate ( 0.1 nM - 0.5 nM) in Phenol 
red-free culture medium for 5 min at 37 °C. 
6. Wash the cells at least 3 times with Phenol red-free culture medium. 
7. Place the culture dish on the microscope stage with mounted heating chamber 
and heat to 37 °C. 
8. The labeling quality can be observed under fluorescent microscope. Punctate 
QDot staining should be visible through the eye piece or CCD detector (Fig. 9). 
Single QDots can be identified by their blinking property. 
9. Acquire time-lapse images at 37 °C. In our experiments, acquisition procedure 
typically lasts for 60 seconds at 10 Hz rate. 
 
 
Figure 2.6 Example live HeLacell imaging of membrane SERT proteins labeled with 
single QDots. (A: bright field, B: fluorescence, and C: surface intensity plot of B). 
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2.6 Tracking Programs for Single-Molecule Analysis 
 Tracking and trajectory construction is a computationally demanding step of 
following single QDot-labeled biological targets through successive images. One of the 
most important determinants of modern single-molecule tracking techniques is the 
nanometer accuracy, which is heavily weighted by the PSF fitting to localize the centroid 
position for sub-pixel resolution, normally demonstrated as a fitting of a 2D Gaussian 
function to a PSF (see Section 2.2). For practical application, estimated background-
corrected intensities of an image are normally filtered out, a necessary step for the 
calculation of centroid position (x0, y0). After locations of single molecules are identified in 
each frame, the next step is to link the detected single-molecule positions. However, 
single QDot blinking brings additional difficulties for the trajectory generation, as the 
spots can temporarily disappear. A practical and most frequently used approach is to 
define a tolerance limit of blinking frames (usually  10 frames) and process an 
additional association step in the trajectory generation algorithm to merge multiple 
trajectories into one.16 This procedure allows tracking to continue and thus compensates 
for the transient data loss caused by QDot blinking. In addition, QDot blinking frequency 
is dependent on the excitation power; hence, it is generally recommended to perform 
single QDot tracking experiments with low power excitation if signal intensity is 
sufficiently high. 
 As the popularity of the single molecule/particle technique expands, 
computational algorithms for tracking have become more widely available. For example, 
particle tracking using IDL,17 developed by Crocker and Grier, provides a total solution 
including 2D Gaussian fit for spot localization, trajectory generation, as well as MSD 
calculation (Fig. 2.7). The algorithms with detailed tutorial are available 
athttp://www.physics.emory.edu/~weeks/idl/index.html. Matlab version of these routines 
can be found at http://physics.georgetown.edu/matlab/. In addition, with recent advances 
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in computing power and numerical software, the development of tracking algorithms has 
evolved rapidly during the past few years in supporting better correspondence for motion 
detection,18 high computational efficiency,19 or 3D motion segmentation and 
localization.20 All the tracking algorithms mentioned above may, however, require 
technical training to operate since they all established under technical computing 
environments such as Matlab, IDL, or C++. 
 
 
Figure 2.7 Snapshot of the interface of Matlab-based particle tracking program originally 
developed from particle tracking using IDL algorithm. Data obtained from 600 frames of 
single QDot imaging. Left panel indicates the 2D trajectory and right panel shows the 
MSD over time. 
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In addition to the tracking algorithms requiring technical computing environments, 
ParticleTracker,21 an ImageJ plugin for single molecule/particle tracking, offers several 
user-friendly features including an easily understandable interface, free on-line tutorial, 
and computationally efficient process. The program is free to download at ImageJ 
website: http://rsbweb.nih.gov/ij/plugins/index.html. Given below is a general tracking 
procedure using ParticleTracker: 
1. Use the File/Open commend in the ImageJ to import the pre-recorded TIF stack 
or uncompressed avi file (Fig 2.11A). If the avi file contains multi channel 
imaging data, use the Image/Color/RGB Split to QDot data channel extraction.  
2. Next, click the Plugins/Particle Detector & Tracker commend. If RGB images or 
images with greater then 8-bits are loaded for tracking, a checkable menu item 
will show up to ask whether the images are converted to 8-bits. If running on a 
computer with fewer than 2GB of memory installed, it is strongly recommended 
to convert to 8-bits to reduce the memory consumption. 
3. As indicated in Fig. 11 B, three basic parameters for particle detection are given. 
Radius: Approximate radius of the particles in the images in units of pixels. 
Cutoff: The score cut-off for the non-particle discrimination. Percentile: The 
percentile (r) that determines which bright pixels are accepted as Particles. Click 
on preview detected and then the successfully detected spots will be circulated. 
Here we recommend to use Radius = 3, Cutoff = 0, and Percentile = 0.1 as 
initial guess, but these values might vary based on the images. Start with our 
recommended parameter and change these values until most of the visible 
particles are detected after clicking the preview button. 
4. After setting the parameters for the detection, set up the particle linking 
parameters (Displacement & Link Range) in the bottom of the dialog window 
(Fig. 2.11B). Here the Displacement parameter means the maximum number of 
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pixels a particle is allowed to move between two succeeding frames. The Link 
Range parameter is used to specify the number of subsequent frames that is 
taken into account to determine the optimal correspondence matching. We 
recommend to use Displacement = 2 and Link Range = 10 as initial guess, and 
again, these parameters can also be modified after viewing the initial results. 
5. Next push the OK button and the result window will then be displayed (Fig. 
2.11C) after seconds to minutes computational calculation (for 600 frames of 
128x128 pixel images takes less than one minute on a regular dual core PC). 
With the Filter Options button given on the dialog window, you can filter out 
trajectories under a given length. Particular trajectory of interest can be selected 
by clicking it once with the mouse left button (as indicated in yellow box of Fig. 
2.11C). 
6. The selected trajectory can be displayed in a separate window by clicking on the 
Focus on Selected Trajectory button. The visualization of the selected trajectory 
can then be saved individually in .gif format (Fig. 2.11D). Detected time-series 
trajectory coordinates can also be exported in a single .txt file for further 
analyses. 
7. After exporting trajectory coordinates, MSD of a specific trajectory can be 
obtained according to the formula below: 
 
ܯܵܦሺ݊∆ݐሻ ൌ ሺܰ െ ݊ሻିଵ ∑ ሾሺݔ௜ା௡ െ ݔ௜ሻଶ ൅ ሺݕ௜ା௡ െ ݕ௜ሻଶሿேି௡௜ୀଵ  [17] 
, where xi and yi are the position of particle on the frame i, t is the-time 
resolution, N is total number of frames, ntis the time interval over which the 
MSD is calculated. 
40 
 
It is important to note that we have tested hundreds of single QDot trajectories 
and found that the algorithm used in the ParticleTracker program can easily cause false 
linking of different molecules/particles between frames. This could lead to incorrect 
trajectory construction. It may be improved by manual re-linking with visual inspection. 
However, potential problems and limitations can still be associated with such manual re-
linking. Due to its respectable efficiency, ParticleTracker program is suitable for 
preliminary screening tests. However, for serious and in-depth analysis, we recommend 
use of particle tracking using IDL or the Matlab-based tracking routines mentioned 
earlier. 
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Figure 2.8 Steps of single QDot tracking using ParticleTracker - an ImageJ plugin. (A) A 
typical raw frame from a time-lapse single-QDot labeling movie. White arrows indicate 
the QDot-labeled target proteins. (B) Image conversion and preview detection from the 
raw frame. Image conversion to Gray 8 is preferred to increase computational efficiency. 
Red circle masks the successfully targeted spots for tracking after executing the Preview 
Detected function. (C) Visualization of all trajectories after executing the Show Detected 
function. Particular area of interest can be selected and zoomed in as indicated in yellow 
box. (D) Time-lapse trajectory from the selected area of interest. Red line drawn 
indicates the "Gaps" in the trajectory. 
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CHAPTER 3 
 
PROBING MEMBRANE DYNAMICS OF LIPID RAFTS WITH  
SINGLE-QUANTUM DOT IMAGING 
 
3.1 Introduction 
Cholesterol-enriched membrane microdomains, known as lipid rafts, have been 
proposed to participate in cellular signal transduction by providing the microenvironment 
necessary for complex protein-protein interactions.1 Early evidence based on the 
simplified membrane models showed that the presence of rigid cholesterol in the 
membrane essentially acts as glue, which packs the sphingolipids and unsaturated 
phospholipids closely together to form a highly directional, organized, and detergent-
resistant state.1 These specialized membrane domains were found abundantly and 
contained sets of associated proteins, especially the glycosyl-phosphatidylinositol (GPI)-
anchored proteins, and were hypothesized to facilitate the regulation of membrane 
proteins through establishing boundaries between the raft and fluid compartments in the 
plasma membrane.1, 2 The roles of lipid rafts in neuronal signaling have received 
increased attention in recent years.3 However, studies on how lipid rafts participate in 
neuronal signaling still mostly rely on biochemical methods, such as using detergents to 
isolate the insoluble membrane fraction,4 which lack dynamic information to help 
decipher the roles of lipid rafts in membrane compartmentalization. 
In this chapter, single QDot tracking was adapted to investigate the membrane 
dynamics of lipid raft constituent ganglioside GM1 in the living RN46A neuronal cells. 
Importantly, our data point to a long-term stability of lipid rafts, as single QDot-labeled 
GM1 complexes show lateral confinement persisting on the order of tens of seconds. 
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3.2 Material and Methods 
3.2.1 Single QDot Labeling of Ganglioside GM1 in RN46A cells 
The immortalized serotonergic neural cell line, RN46A, was provided by Dr. 
Whittemore (University of Miami School of Medicine).5 RN46A cells were cultured in 
DMEM/F12 (1:1; Life Technologies, Grand Island, NY) supplemented with 10% FBS and 
incubated in a humidified atmosphere with 5% CO2 at 37°C. For experiments involving 
the labeling of ganglioside GM1 in the plasma membrane, RN46A cells were first 
incubated with 200 nM biotinylated CTxB (CTxB:biotin molar ratio ≈ 1:1 to avoid cross-
linking, Sigma, St. Louis, MO) for 30 min prior to a 5 min 0.5 nM SAv-QDot (Life 
Technologies, Grand Island, NY) incubation. Importantly, ganglioside GM1-CTxB 
association has been shown to elicit endocytosis.6 To avoid endocytosis and to achieve 
successful assessments in membrane dynamics, all optical live-cell time-lapse image 
series were taken immediately after QDot labeling. 
 
3.2.2 Microscopy  
Confocal images were obtained on a Zeiss LSM 5 Live confocal system (Carl 
Zeiss Jena GmbH, Jena, Germany) and viewed with a Zeiss 63×/1.4 NA oil immersion 
objective lens. Excitation was provided by a 488 nm 100-milliwatt diode laser. Single 
QDot emission was collected using a bandpass 610/20 mm filter (for QDot 605) or a long 
pass 650 mm filter (for QDot 655). Each sequence of time-lapse images was acquired at 
10 frames per second for 30 -60 seconds with scan format of 512×128 pixels. All live-cell 
imaging were performed at 37 °C. Analysis of raw data images were processed using 
Zeiss LSM Image Examiner. 
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3.2.3 Subpixel Localization and Trajectory Generation 
To calculate a subpixel estimate of single QDot position, the single QDot intensity 
distribution (Fig. 1C) was fitted with a 2D Gaussian function:7 
2 2
0 0
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( ) ( )
0
x x y y
w
xyI A A e
      [1] 
, where Ixy is the intensity of the pixel, x0 and y0 is the designated local maximum 
coordinates of the Gaussian, A is the amplitude of the signal with local background A0, 
and w is the width of the Gaussian curve. Note that the coordinate (x0, y0) acquired by 
2D Gaussian fit is not a true position but only an estimate. The accuracy is dependent 
upon the respective signal-to-noise ratio (SNR), which is defined as:  
0
0
2 2
bg I
ISNR   
 [2] 
, where I0 is the maximum signal intensity above background, 2bg  is the variance of the 
background intensity values, and 
0
2
I is the true variance of the maximum signal intensity 
above the background. Since w width is approximately equal to the wide-field diffraction 
limit (for visible light is about 250 nm), the uncertainty of the fitted coordinate () is 
approximately given by: 
250
SNR
   (nm) [3] 
which is ±10-15 nm in our case (3 independent experiments, n = 873). In addition, QDot 
blinking was used to assure single-molecule events. For trajectory generation, raw data 
files were extracted to generate stacks of individual 16-bit TIF images and then 
processed with Matlab (the MathWorks, Inc., Natick, MA) routines originally developed 
by Jaqaman K. and colleagues.8 
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3.2.4 Instantaneous Velocity 
 The distribution of single step displacement over a time increment (100 ms in our 
case) was carried out to calculate the instantaneous velocity. For temporary lateral 
confinement of a diffusing protein due to local environmental constraints such as 
interaction with lipid rafts or cytoskeletal corrals, the motion  pattern can be best 
described as anomalous subdiffusion.9 The statistical distribution of instantaneous 
velocities is thus close to a Lévy function instead of a Gaussian function, which is given 
by: 
12
0( ) 1 x xf x r
r

          
 [4] 
, where x0 is the location parameter (the best fit instantaneous movement) and r 
represents the interquartile range (the half-width at half-maximum) of the fitted step 
distance, meaning the statistical dispersion of the probability distribution. For practical 
applications, the Lévy probability distribution function can be simplified as a truncated 
Cauchy distribution:  
12
0( ) 1 x xf x b
a
         
 [5] 
, where a andb are only treated as fit coefficients in the defined function, and the 
goodness of the fit is judged by the R2 value. In all of our analyses, the R2 values of the 
fit of instantaneous velocity are higher than 95 %, indicating high reliability of our fits. 
 
3.2.5 Diffusion Coefficients and Membrane Confinement 
After exporting trajectory coordinates, mean-square displacement (MSD) values 
for individual trajectories were calculated according to the formula listed below:10 
 11 2 2
1
( ) ( 1 ) [( ( ) ( )] [( ( ) ( )] ]
N n
j
MSD n t N n x j t n t x j t y j t n t y j t
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
                [6] 
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, where [x(jt+ nt) , y(jt+ nt)] are the position of the QDot starting at position [x(jt) , 
y(jt)], t is the time resolution, N is total number of frames, nt is the time interval over 
which the MSD is calculated. To achieve statistical significance, single QDot trajectories 
without a minimum of 100 time steps were discarded. 
In a two-dimensional Brownian motion, also known asrandom walk, the MSD 
over time is linear. The standard method to calculate the diffusion coefficient D is to 
perform a linear fit of MSD over time since the MSD is given by:  
MSD(t) = 4DΔt [7] 
, where Δtis the time-resolution. 
 For the case of confined diffusion, which is evident by a negative curvature on 
the MSD over time plot, we followed the method described by Daumas et al.10 The MSD 
is given by 
2 /( ) 2 (1 e ) 4t MMSD t L D
    , and 
2
2
L
D
   [8] 
, where a short-term diffusion coefficient,Dµ, isused to describe a rapid, “microscopic” 
diffusion behavior, and a long-term diffusion coefficient,DM, indicatesaslower, 
“macroscopic” movement. L is the characteristic size of the short-termconfiningdomain 
and is the so-called “equilibration” or “relaxation” time on the short time-scales.  
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3.3 Results 
3.3.1 Instrument response and single-molecule sensitivity inspection 
 To ensure spatial and temporal resolution of our imaging approach, carboxyl 
functionalized, amphiphilic poly(acrylic acid) polymer-coated QDots (AMP QDots) were 
first spin-casted onto a cover glass and then observed on a Zeiss line-scanning confocal 
microscope system (Fig. 3.1).11 Time-lapse fluorescence imaging of QDots was used to 
assess temporal and spatial characteristics of single QDot fluorescence (Fig. 3.2 upper 
panel). In addition, Qdot blinkingwas demonstratedas a single-molecule criterion (Fig. 
3.2 lower left panel).12, 13 Furthermore, the intensity distribution coming from a single 
QDot shows a diffraction-limited pattern (Fig. 3.2 ROI 3, lower right panel), representing 
another signature of single-molecule.14 Further analysis using 2D Gaussian fit of the 
intensity distribution provides an estimate of the localization of a single QDot with 
accuracy measured at 10~15 nm (see section 2.2).7 
 
Figure 3.1 Schematic of the optical setup of the line-scanning confocal microscope. 
Through the use of the cylindrical lens (CL), single point laser light is recreated to form a 
pupil plane. This line excitation is then directed to Achrogate (left inset) for sample 
excitation. Fluorescent signal which passes the Achrogate and pinhole optics is collected 
onto the line detectors. 
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Figure 3.2 Visualization of single QDots on a glass support. Upper panel provides a 
single frame from time lapse imaging of QDots taken with the high-speed line scanning 
confocal microscope at 10 Hz scan rate. Spin-casting ITK carboxyl-modified 605 nm 
QDots were immobilized on the glass coverslip bottomed MetTek dish for imaging. Two 
randomly selected blinking QDots (ROI 1, ROI 3) and a randomly selected background 
region (ROI 2) are indicated by circles. Scale bar = 10 µm. Lower left panels provide 
time-dependent intensity traces of the selected ROIs. Fluorescence intensity of ROI 1 
QDot is constant during the “on” state and shifts to a similar intensity level as 
background indicated by the intensity time trace of ROI 2. A 3D intensity plot of QDot 
(ROI 3) was used to provide an estimate of the spatial resolution achieved with our 
imaging paradigm (central position uncertainty = ±10~15 nm, one pixel = 200 nm). 
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3.3.2 Basal membrane diffusion in living RN46A Cells 
 Several previous studies have indicated that water-soluble AMP QDots, which 
were generated from passivating the hydrophobic QDots with amphiphilic polymers, 
nonspecifically interact with the cellular membrane via hydrophobic interaction.15, 16 This 
artifact of QDot biological staining turns out to be a successful molecular probe for 
studying the lateral mobility of the neuronal membrane. To ensure the spatial separation 
of single QDots in regions greater than the diffraction-limited distance for single molecule 
tracking, AMP QDots are used at an extremely low concentration (< 10 picomoles) in 
RN46A cells. Fig. 3.3 shows typical trajectories of AMP QDots attached on the surface 
of a living RN46A cells via hydrophobic interaction. Although various moving patterns 
can be observed, the majority of trajectories exhibit a distinct, Brownian-type motion 
mode. We must also note that neither distinct orientation nor clear membrane 
compartmentalization is predominantly displayed (Fig. 3.4), suggesting that no particular 
force governs the motion of AMP QDots in the plasma membrane (i.e. active 
movements). To gain a quantitative assessment of the velocity of the diffused QDots, we 
analyzed the distribution of instantaneous velocity (single step displacement over a time 
increment  = 100 ms, see methods). As shown in Fig.3.3B, single AMP QDots display a 
bimodal distribution of instantaneous velocity with a majority falling in the fast population 
(slow = 0.51 ± 0.03 m/s, 11.6%; fast =1.46 ± 0.04 m/s, 88.4%). 
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Figure 3.3 Trajectories and instantaneous velocity of AMP QDots non-specifically bound 
to the plasma membrane of living RN46A cells. (A) A single frame from a time-lapse 
recording of single AMP QDots diffuse in the native membrane of a RN46A cell that was 
superimposed upon the trajectories throughout the recording. Trajectories on the right 
are 4X zoom-in of the selected ones on the left, and green arrows note the blinking 
events. Although the motion of AMP QDots can be generally categorized as being one of 
two types — confined (as indicated in box 1) or non-confined (as indicated in box 2), 
trajectories shown a non-confined pattern are dominantly displayed. (B) The 
instantaneous velocity plot of AMP QDots is shown for the data from 4122 steps. The 
data points are well-fitted to a bimodal distribution where a majority falling in the fast 
population (slow = 0.51 ± 0.03 m/s, 11.6%; fast =1.46 ± 0.04 m/s, 88.4%). 
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Figure 3.4 Membrane diffusion of AMP QDots shows a non-directional random walk. (A) 
Magnitude of x- and y- directional displacements of all collected trajectories over the 
same time-period recording (30 sec, n=43). (B) Vector representation of all collected 
trajectories over the same time-period recordings. All starting coordinates are 
normalized to the central position. 
 
3.3.3 Single quantum dot tracking of lipid raft constituent ganglioside GM1 
 To perform single QDot tracking of lipid raft constituent ganglioside GM1, a two-
step labeling approach was implemented in which RN46A cells were initially incubated 
with biotinylated cholera toxin B subunit (CTxB),6, 17 a protein that binds specifically to 
ganglioside GM1, followed by the incubation with streptavidin-conjugated QDots (SA-
QDots). The single molecule property of the QDot conjugates was further evaluated via 
blinking behavior inspection (Fig. 3.5A). Shown in Figure 3.5B are typical trajectories of 
single QDot-GM1 complexes in the membrane of RN46A cells, where apparently only 
the confined motion pattern can be found. The analysis of the distribution of 
instantaneous velocity was then carried out to correlate the confined movements (Fig. 
3.5C). As expected, the distribution is well-fitted with a single population and the fitted 
instantaneous velocity was estimated as  = 0.88 ± 0.03 m/s. 
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Figure 3.5 Trajectories and instantaneous velocity of single QDot-conjugated GM1 
complexes in the plasma membrane of living RN46A cells. (A) Representative snapshots 
from a time-lapse series of single QDot-GM1 complexes via the bridge of CTxB. The 
white circles indicate the QDot being followed and the dash circle (t = 25.7 sec) notes a 
blinking event (scalebar = 1.5 m). (B) A single frame from a time-lapse recording of 
single QDots bound to GM1 in the native membrane of a RN46A cell that was 
superimposed upon the trajectories throughout the recording. Three representative 
trajectories (right boxes) show a confined motion pattern and their 4X zoom-in (left 
boxes) are displayed. (B)  The instantaneous velocity plot of AMP QDots is shown for 
the data from 3240 steps. The data points are well-fitted to a single distribution ( = 0.88 
± 0.03 m/s). 
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 The dependence of the mean square displacement (MSD) on the time interval 
was then used to dissect the lateral diffusion and membrane confinements (Fig. 3.6). As 
seen in Fig. 4A, the diffusion of AMP QDots in the membrane appears to be Brownian 
since a linear correlation of MSD with time can be observed. From the linear fit, we 
obtained a diffusion coefficient D = 0.393 ± 0.002 m2/s (mean ± SEM), similar to the 
reported diffusion coefficients of lipid probes in the native membrane on the order of 
0.1~1 m2/s.18 In comparison, the MSD versus time plot of single QDot-labeled 
ganglioside GM1 shows a curvature, indicating restricted diffusion. Consequently, a 
confined diffusion mode was used to calculate the diffusion coefficient and the 
characteristic size of the short-termconfiningdomainL(seesection 2.3), yielding the values 
of D = (7.87 ± 0.04)×10-2m2/s and L= 198 ± 33 nm. The diffusion distributions of AMP 
QDots and QDot-labeled GM1 were further evaluated using a cumulative probability plot 
(Fig. 3.6). Although visual inspection only shows minimal overlap between the two cases, 
the diffusion coefficients of QDot-labeled GM1 are mostly restricted to the slow 
timescales (10-2~10-3m2/s), whereas AMP QDots in the membrane diffuse significantly 
faster (p value <0.05, Shapiro–Wilk test) and exhibit a large range of diffusion rates. 
 The diffusion dynamics of QDot-labeled GM1 molecules in comparison to AMP 
Qdots suggests that lipid rafts in cell membrane produce a strong stabilization effect. We 
therefore sought to take advantage of the inherent photostability of QDots to follow GM1 
movements over longer time-scales (30-60 seconds). Shown in Figure3.7 is a 
spatiotemporal 3D graph of QDot-labeled GM1 complexes in the native membrane of 
RN46A cells, where the majority of individual QDot-GM1 complexes exhibit movements 
less than 1 m in distance throughout the entire recording. In comparison, ~80% of the 
AMP QDots display overall movement larger than 1 m (Fig. 3.4B, n = 43). 
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Figure 3.6 Comparison of diffusion behavior of single AMP QDots and QDot-labeled 
GM1 complexes in the RN46A cells. (A) Averaged MSD as a function of time for single 
AMP QDots. Solid gray line is computed based on linear regression, indicating a simple 
diffusion. (B) Averaged MSD as a function of time for single AMP QDot-GM1 complexes. 
Solid gray curve is the best fit based on an exponential function (see methods), 
indicating a confined diffusion. (C) Cumulative distribution of the diffusion coefficients. 
Blue shadow which indicates 10-3<D< 10-2 is used for visual comparison. 
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Figure 3.7 Spatiotemporal 3D representation of movement of the single QDot-GM1 
complexes in living RN46A cells. Fluorescent intermittency (“blinking”) of a single QDot 
on an example trajectory is noted by a black arrow. 
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3.4 Summary 
 The diffusion coefficient,D, dwelling time,, and the putative confinement 
domain,L, of lipid rafts have been previously estimated by various approaches. The 
study presented herein was designed to directly follow the motion of a lipid raft 
constituent GM1, while the native membrane integrity was preserved. Using a single 
QDot labeling approach, we reveal GM1 comprised lipid rafts slowly diffuse within a 
confinement zone, which has a diameter of ~200 nm. Further inspection of the long-term 
time-dependent trajectories (Fig. 5) features the persistent confinement of lipid rafts in 
RN46A cells (L = 200 nm, D = 7.8 × 10-2m2/s,> 10 s). In comparison, Schütz et al. 
adopted liposome-facilitated delivery of a saturated acyl-chain fluorescent lipid probe 
(1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine, DMPE-Cy5) for single-molecule 
tracking. In their analyses, lipid rafts were found to be localized in relatively larger 
partitioning domains along with faster diffusion rates and a long dwelling time in HSAM 
cells (L= 0.2 - 2 m, D = 0.6-0.9 m2/s,~ 13 s).19 Interestingly, a recent stimulated 
emission depletion (STED) microscopy study reported by Eggeling et al. showed that 
lipid raft-associated constituents, including the sphingolipids and GPI-anchored proteins, 
are transiently trapped in nanoscale domains for only tens of milliseconds with a 
relatively slower diffusion rate in the PtK2 cells (L< 20 nm,D = 2 ×10-2m2/s,  = 10 ~ 20 
ms).20 As lipid rafts are known to contain various components and participate in dynamic 
membrane trafficking and signaling, it is perhaps not surprising that differences in 
detecting approaches, experimental time-resolutions, targeted molecules, as well as cell 
models would have a substantial impact on the estimates of raft diffusion properties. 
Clearly, a systematic examination of various lipid raft constituents is required for a more 
general understanding of membrane dynamics of lipid rafts. 
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Presently how lipid rafts contribute to biological signaling is an open question. A 
closely related point of view is that, for a lipid raft to be able to act as a signaling platform, 
the lifetime of a lipid raft should be at least partially relevant to a biological signaling 
duration (i.e. the timescales over which biological signaling persists). Since protein 
signaling networks typically operate on timescales of seconds to minutes, the lifetime of 
lipid rafts are likely to exist on similar timescales, which is consistent with the findings 
reported in this study. In addition, if lipid rafts are membrane subdomains that facilitate 
the signaling of raft-associated proteins, proteins residing in the lipid rafts should share a 
similar confined diffusion mode as we observed in this research. In a recent study, 
Andrews et al. followed the motion of individual high affinity IgE receptors (FcεRI), a 
class of raft-dependent receptors, with monovalent antibody-conjugated QDots in living 
cells and identified confined diffusion with seconds of cross-linking in FcεRI signaling.21 
A similar confined diffusion mode was observed with single QDot labeled GPI anchored 
proteins,227 neuronal nicotinic acetylcholine receptors,23 and serotonin transporters.24 
However, the question of whether lipid rafts dynamically govern protein signaling 
remains unanswered. Consequently, a multichannel single QDot tracking protocol for 
simultaneous multi-target analysis (i.e. one color of QDot labeling for raft constituent and 
another color of QDot labeling for the raft-associated protein) may hold high potential in 
the acquisition of information to address the above question. 
 As mentioned in the introduction, common attempts to perform real-time tracking 
of membrane constituents mostly rely on the use of organic fluorophores or micron to 
submicron-sized polymeric particles. The main advantage of organic fluorophores in 
real-time tracking is their small size ( 1 nm). This property makes them particularly 
useful for tracking movements of individual receptors in distinct subcellular structures 
such as synapse or caveolae.25 Up until now, the real bottleneck of dye-based single-
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molecule microscopy is still the photostability of the organic fluorophores, which limits 
the tracking time to only a few seconds.25, 26 In contrast, polymeric particles, owing to 
their superior strength in photostability, have been popularly used for following 
membrane dynamics since the 1990's.27 However, the large size of the particles (> 100 
nm), which inevitably leads to cross-linking of the labeling targets, call into question the 
diffusion characteristics measured.28 So how can we address these shortcomings from 
both sides? The current best compromise is perhaps the use of photostableQDots for 
real-time tracking. Although the diameter of QDots compared to the organic fluorophores 
is still relatively large (10-20 nm) and the monovalent QDots are not commercially 
accessible, with appropriate adjustment in conjugation protocol (i. e. fine-tune the 
QDot/ligand molar ratio in conjugation conditions)18, 29 single QDot tracking can be 
regarded as a single-molecule technique. Importantly, differences of QDot-conjugated 
and dye-conjugated approaches in measured diffusion coefficients are minimal,18, 25, 30 
indicating the applicability of QDots to substitute organic fluorophores for single-
molecule tracking. 
 In conclusion, our single-QDot tracking study documents the diffusion properties 
of ganglioside GM1 in the plasma membrane of RN46A cells. The valuable information 
on membrane dynamics of lipid rafts as well as our straightforward, readily transferrable 
single QDot experimental protocol presented herein may form a basis for not just raft 
studies but also membrane protein research in living cells. It will be interesting to dissect 
the functional implications of the lateral confinement of lipid rafts in the neuronal 
membrane. In a preliminary treatment study, we observed a non-Brownian, actin 
cytoskeleton-dependent membrane dynamic in GM1 movements.24 Further analysis of 
the connection between lipid rafts and cytoskeleton may yield useful insights into the 
compositional heterogeneity of lipid raft-associated signaling.2  
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CHAPTER 4 
 
SINGLE MOLECULE ANALYSIS OF SEROTONIN TRANSPORTER REGULATION 
USING ANTAGONIST-CONJUGATED QUANTUM DOTS 
 
4.1 Introduction 
 In the brain and periphery, signaling by the neurotransmitter serotonin (5-
hydroxytryptamine, 5-HT) relies on efficient, transporter-mediated reuptake to terminate 
synaptic signals. The presynaptic, antidepressant-sensitive 5-HT transporter (SERT, 
5HTT), encoded in humans by the SLC6A4 gene, is primarily responsible for 5-HT 
clearance and has been the focus of much attention as a determinant of 
neuropsychiatric disease risk.1 Both transcriptional and post-translational mechanisms 
exert powerful control over SERT-mediated 5-HT transport, though many aspects of 
SERT regulation are as yet ill-defined.2 SERT is known to undergo both regulated 
membrane trafficking as well as transitions between low and high activity states, with 
multiple, intracellular signaling pathways involved, including pathways linked to the 
activation of PKC, PKG and p38 MAPK.2, 3 These stimuli may act directly, for example 
via transporter phosphorylation.3, 4 Additionally, biochemical studies indicate that SERT 
exhibits dynamic associations with cytoskeletal binding proteins.2, 5 As altered 
posttranslational regulation of SERT by these mechanisms is a feature of coding 
variants identified in subjects with obsessive-compulsive disorder (OCD) and autism,6-9 a 
more detailed mechanism that supports regulation of the wildtype transporter is needed. 
Biochemical studies that assess the distribution of large populations of molecules 
indicate that SERT proteins and related transporters localize to cytoskeleton-associated, 
cholesterol-rich membrane microdomains, compartments that may also dictate aspects 
of transporter regulation.5, 10, 11 Such studies, however, do not provide sufficient 
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resolution to monitor the behavior of individual molecules that, collectively, contribute to 
the macroscopic features of transporter behavior. Ion channels can be monitored at the 
single molecule level by patch clamp recording techniques. Generally, cell surface 
transporters and receptors cannot be studied with this approach due to low or absent 
electrogenicity needed for patch-clamp recordings. Antibody-based optical methods 
have been utilized to identify a few single membrane proteins,12, 13 however, many 
proteins lack suitable extracellular domains that can be targeted by antibodies without 
functional disruption. Taking advantage of their remarkable brightness and extraordinary 
photostability properties, quantum dots (QDots) are increasingly being used for the 
detection of biomolecules in living cells.14-16  Compared to conventional ensemble 
biochemical methods, single-QDot tracking allows for a detailed biophysical 
characterization of protein movements that can provide a real-time report of the unitary 
events associated with regulation.13 In this report, we implement a ligand-conjugated 
QDot approach17 to monitor single QDot-labeled SERT proteins in living, neuronal cells, 
providing evidence that actin-based mechanisms dictate p38 MAPK-dependent 
transporter activation. More generally, our successful use of QDots targeted to cell 
surface proteins by high-affinity ligands establishes a paradigm that should be of broad 
utility in defining the single molecule behavior of drug targets. 
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4.2 Materials and Methods 
4.2.1 Cell Culture, Treatments, and SERT Activity Assay 
 The immortalized serotonergic neural cell line, RN46A,18 was provided by Dr. 
Whittemore (University of Miami School of Medicine). Cells were cultured in DMEM/F12 
(1:1; Gibco) supplemented with 10% FBS and incubated in a humidified atmosphere with 
5% CO2 at 37°C. Although RN46A cells endogenously express functional SERT proteins, 
an increase in SERT expression can be obtained by incubating cells in DMEM/F12 (1:1) 
containing a 1% B27 supplement (Invitrogen) plus 1 μM 5-HT for 24 hours prior to single 
molecule labeling experiments. 
 For experiments involving peptide treatments, RN46A cells were preincubated 
with a synthetic peptide at 10 μM for 30 min (37 °C; 5% CO2) prior to the assay. 
Synthetic peptides (>95% purity) used in the study were purchased from Thermo 
Scientific, and carried the sequences as followed:  
C-SERT: YGRKKRRQRRR(TAT)-ETPTEIPCGDIRMNAV 
U-SERT: YGRKKRRQRRR(TAT)-PGTFKERIIKSITPETPREI 
 SERT activity in living RN46A cells was examined by using IDT307, a fluorescent 
neurotransmitter substrate.19 IDT307 is nonfluorescent in solution but fluoresces as the 
substrate is accumulated, affording real time kinetic evaluation of SERT activity. A 
straightforward assay to verify successful SERT expression in RN46A cells simply 
involved the addition of IDT307 directly to the culture media at a final concentration of 5 
μM and incubating at 37 C for 30 minutes. Time-lapse fluorescent images were then 
acquired immediately after IDT307 addition, and successful transporter expression was 
evident by an observable increase in intracellular fluorescence. No additional rinsing was 
required since IDT307 is only fluorescent in intracellular environments, and any excess 
of IDT307 in solution did not result in any observable fluorescent background. 
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4.2.2 Labeling RN46A Cells with Ligand-Conjugated Quantum Dots 
 For single QDot labeling of SERT proteins, biotinylated IDT318 ligand was first 
incubated with RN46A cells followed by three washes to remove unbound ligand. 
Streptavidin-conjugated Quantum Dots (SA-QDots) (Invitrogen) were then added to 
detect the biotinylated moiety of antagonist-associated linker. To minimize the possibility 
of cross-linking of ligands and the overlap of QDot trajectories, we adapted the QDot-
based, single molecule labeling protocol of Triller and colleagues 20, where the ligand 
concentration (0.5 μM) is set well below saturation (saturation concentration:  10 μM). 
In addition, low concentrations (0.5 nM) of SA-QDots were used to detect ligand binding 
at the lowest recommended concentration as studied by Triller and colleagues 20.  
 For experiments involving cholesterol depletion, cells were incubated with 5 µM 
methyl-β-cyclodextrin (MβCD) (Sigma) at 37°C for 30 min prior to two-step QDot-SERT 
labeling. The MβCD cholesterol depletion protocol we utilized does not result in overt 
changes in RN46A cell morphology, though more prolonged incubations (90 min) of 
RN46A cells with 10 m MβCD at 37 °C produce cell rounding paralleled by a decrease in 
SERT mobility. 
 For experiments involving the labeling of plasma membrane GM1 ganglioside, 
RN46A cells were first incubated with 0.2 µM biotinylated cholera toxin subunit B (CTxB) 
(CTxB:biotin molar ratio ≈ 1:1 to avoid cross-linking, Sigma) for 30 min prior to a 5 min 
0.5 nM SAv-QDot incubation. Importantly, GM1 ganglioside-CTxB association has been 
shown elicit endocytosis.21, 22 To avoid endocytosis and to achieve successful 
quantification in dual-channel imaging, all optical live-cell images were taken 
immediately after QDot labeling. Endocytosis from longer labeling experiments could be 
readily detected by an accumulation of larger clusters of QDots within the endosomes. 
 
  
69 
 
4.2.3 Microscopy 
 Confocal images were obtained on a Zeiss LSM 510META confocal imaging 
system. A dual fluorescent, Differential Interference Contrast (DIC) imaging setup was 
used for conventional point scanning confocal microscopy. Images were collected using 
a Zeiss Plan-Apochromat 63×/1.4 numerical aperture (NA) oil immersion objective lens 
and excited by an Argon laser at 488 nm. All images were 512×512 pixels in size and 
had an 8-bit pixel depth. IDT307 or Alexa 488-labeled CTxB signals were collected 
through a 520/20 bandpass filter. QDot655 labeling was collected through a 650 nm long 
bandpass filter. Dual channel fluorescent signals were collected individually to ensure 
that fluorescent signals could be selected without emission wavelength overlap. Images 
were processed using Zeiss Image LSM Examiner or Matlab routines originally designed 
by Esposito A. and colleagues.23 All images acquired for comparison were thresholded 
equivalently. 
For high speed line-scanning confocal microscopy, images were obtained on a 
Zeiss LSM 5 Live confocal system and viewed with a Zeiss 63×/1.4 NA oil immersion 
objective lens. Excitation was provided by a 488 nm 100-milliwatt diode laser. Imaging 
was performed at 37 °C. Single QDot emission was collected using a long pass 650 filter. 
Line scan images with scan format of 512x128 pixels were processed using Zeiss LSM 
Image Examiner. 
 
4.2.4 Data Analysis of Single Quantum Dot Imaging 
 Raw data files were extracted to generate stacks of individual 16 bit TIF images 
for single molecule analyses of velocity and trajectory, performed using MATLAB 
routines. For details, see section 3.23- 3.2.5 
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4.3 Results 
4.3.1 Single Molecule Analysis of QDot-labeled SERT Reveals a Membrane 
Microdomain-Associated Subpopulation of Transporters With Confined Diffusion 
 The schematic in Figure 4.1A illustrates our QDot-SERT labeling strategy and 
depicts the chemical structure of our custom-synthesized SERT ligand, IDT318, which 
consists of the indoleamine derivative 5-Methoxy-3-(1,2,5,6-tetrahydro-4-pyridinyl)-1H-
indole,24 attached to a biotinylated polyethylene glycol (PEG 5000) linker via an alkyl 
spacer. The ligand has been previously shown to act as a competitor for SERT-
dependent, 5-HT uptake and antagonist binding,24, 25 and the ligand specificity and 
affinity were previously described in detail.25 A two-step labeling of SERT by SA-QDots 
was designed to permit fluorescence-based detection of surface SERT proteins. We 
labeled single SERT proteins in differentiated, RN46A cells that are derived from rat 
embryonic raphe neurons.18 These cells express low levels of SERT, facilitating the 
tracking of single SERT molecules.26 We monitored single SERT proteins in living 
RN46A cells across 10 sec time-lapse sequences at 10 Hz (Fig.4.1B), where individual 
QDots show a pattern of fluorescence intermittency (“blinking”), a hallmark of single 
QDot detection.27 
Adkins and co-workers,28 utilizing transfected cells and conventional fluorescence 
methods to study transporter populations, visualized dopamine transporters in 
cholesterol-rich membrane microdomains (often referred to as “lipid rafts or “membrane 
rafts”).29, 30 Magnani and co-workers,10 using classical biochemical approaches, provided 
evidence that extraction of membrane cholesterol from brain preparations reduce SERT 
activity. To determine whether native SERT associates with these microdomains in living, 
neuronal cells and whether these domains represent membrane rafts, we performed 
dual-color, live-cell confocal imaging of RN46A cells18 with the two-step labeling 
methods as described above. Cholesterol-rich microdomains were identified using Alexa 
71 
 
Fluor 488-conjugated CTxB, a protein that binds specifically to ganglioside GM1, a 
molecule that has previously been shown to localize to membrane rafts.31 As shown in 
Figure 4.1C, images of RN46A cells revealed extensive CTxB/SERT co-labeling, 
including the presence of single particles as defined above. To verify that the pattern of 
the clustered SERT/GM1 co-labeling indeed derives from cholesterol-rich membrane 
microdomains; we extracted cholesterol with methyl-β-cyclodextrin (MCD), followed by 
subsequent dual marker labeling.11 As predicted, this manipulation dispersed the 
punctate labeling of both CTxB and QDot-SERT labeling of RN46A cells (Fig. 4.1C, 
Right). 
Next, we obtained real-time trajectory data for single QDot-SERT complexes under 
control and MCD-treatedconditions (Fig. 4.2A-B). Inspecting these trajectories reveals 
that lateral movement of single SERT molecules are nonuniform in both cases, with a 
mixture of movements distinguished by distinct rates but with a relative continuity of 
motion. Notably, single QDot complexes predominantly display limited movement under 
control conditions (Fig. 4.2A), whereas single SERT proteins in cholesterol-depleted 
cells displayed noticeably accelerated, lateral movements (Fig. 4.2B). 
For the demonstration of standard protocols for diffusion analyses prior to an 
introduction of analyses for larger ensembles, a representative time-lapse example from 
each group is given (Fig. 4.2C). In Figure 2D, we quantified the impact of MCD on time-
dependent displacements (step movements) of single QDot-SERT complexes. As 
revealed in the greater slope of particle displacement, plotted as a function to time, 
cholesterol-depleted conditions resulted in significantly faster QDot-SERT movements 
(red trace) (P<0.0001 from averaged traces, Student’s t-test), consistent with a 
mobilization of transporters following disruption of membrane microdomains. These 
elevated step velocities can be derived from confined diffusion, Brownian movement, or 
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directed movement, and thus do not describe how a target protein interacts with the 
surrounding membrane microenvironment. Since single QDot-labeled SERT proteins 
predominantly displaied limited movement (Fig. 4.2A), we assumed that single SERT 
proteins are restricted to membrane microdomains. In that case, the diffusion property of 
single SERT proteins can be appropriately characterized as anomalous subdiffusion,32 a 
time-dependent decrease of the diffusion coefficient as a result of temporary 
confinement (i.e. interaction with lipid rafts or cytoskeletal corrals) of a diffusing protein.33 
Following the relation between transient diffusion coefficient D(t) and tracking time 
lags(t), free diffusion versus anomalous subdiffusion can be readily distinguished by a 
plot of log D(t) versus log t (log-log plot), in which a line of negative slopereflects 
subdiffusion whereas a horizontal line indicates free diffusion. The transient anomalous 
diffusion coefficient D(t) can be calculated as the mean squared displacement (MSD or 
r2), D (t)=r2 t, where  is the anomalous exponent.32 Shown in Figure 4.2E is the 
log-log plot of single SERT proteins using the same position data as shown in Figure 
4.2D. As expected, the single QDot-SERT complex under control condition exhibited 
restricted, anomalous subdiffusion. In contrast, and consistent with macroscopic 
assessments, the diffusion property of single SERT protein is best fit to a model 
dominated by free diffusion after MβCD treatment. 
To further distinguish transporter movements from control and cholesterol-depleted 
cells, we inspected the trajectories of a larger number of single SERT molecules. 
Consistent with the findings from the representative experiments indicated in Figure 
4.2C, examination of total displacement of single SERT molecules as a function of time 
(n>50, from 3 independent experiments) demonstrates an approximately two times 
faster average rate of movement for MβCD treated cells versus control cells (Fig. 4.3A). 
Since the single SERT trajectories collected in our experiments varied from 5 to 30 sec 
in duration, using the mean slope from the total displacement over time to calculate 
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single SERT velocity could have impacted our results. A better assessment of single 
SERT mobility can be achieved by the calculation of an instantaneous velocity where the 
distribution of a single step displacement (x) can be fitted into a Lévy probability 
distribution function (see Materials and Methods). Note that the dynamic behavior of 
nanoscale assemblies in the plasma membrane of live cells must be observed on the 
subsecond timescale or below,34 hence our use of an instantaneous velocity approach. 
Although the PEG linker we utilized to tether the SERT ligand appears to reduce the 
steric interference of QDots with SERT, this linker may also increase the uncertainty of 
SERT velocity assessments. We minimized this uncertainty by calculating instantaneous 
velocity from a large ensemble of instantaneous displacements (>3000). From these fits, 
we determined a mean, instantaneous velocity of QDot-SERT molecules of 0.75 ± 0.06 
m/s (mean ± 95% confidence limits) in untreated cells (Fig. 4.3B). Consistent with our 
mean slope-based estimates, fits from MβCD-treated cells yielded a significant increase 
in instantaneous velocity (1.74 ± 0.08 m/s, P<0.0001, Student’s t-test). The log-log plot 
of MCD-treated cells also clearly show an increase in slope, indicative of reduced 
constraints on lateral mobility (compare Fig. 4.4A and Fig. 4.4C). The population 
distribution of single particle diffusion coefficients from untreated cells reveals two 
components (Fig. 4.4B) with a majority of the SERT proteins residing in the component 
with lower diffusion coefficients (10-3~10-2m2/s). In contrast, only a single distribution of 
diffusion coefficients could be detected for SERT proteins in MβCD-treated cells (Fig. 
4.4D), matching the minority population detected in untreated cells (10-2~10-1m2/s). 
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Figure 4.1 Tracking of QDot-labeled single SERT proteins. A, Schematic of QDot 
nanoconjugates for SERT labelling. The SERT ligand (IDT318) incorporates a biotin 
moiety to permit conjugation by SAv-QDot, a PEG chain to reduce steric interference 
and non-specific binding, an alkyl spacer to provide accessibility to the binding site, and 
a SERT-selective drug derivative to facilitate specific recognition of SERT. B, Time 
series images of single QDot-SERT proteins on the surface close to the cell body (left 
column) or neuritic process (right column) of living RN46A cells. Time points where 
QDot-labeled SERT proteins exhibit “blinking” are indicated by the dashed circles. C, 
Presence of SERT proteins within GM1 enriched membrane microdomains and their 
mobility in control and cholesterol depleted cells. 1st column: DIC images. 2nd column: 
staining of membrane rafts using Alexa 488-conjugated CTxB. 3rd column: QDot-SERT 
proteins. 4th column: colocalization of CTxB and QDot labeling. Arrowheads note the 
presence of puncta labeled for both markers. 
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Figure 4.2 Single QDot-SERT tracking in living serotonergic RN46A cells under control 
and MCD-treated conditions. A, Full trajectory reconstruction from 30 sec time-lapse 
videos of single QDot-labeled SERT proteins in control A and cholesterol depleted B 
RN46A cells. Video frame size: 512X128 pixels, pixel size: 0.2 µm. Note the more 
mobile behavior of single SERT trajectories after MCD treatment. C, Temporal profile of 
representative QDot-labeled, single SERT proteins with and without MCD treatment. D, 
Comparison of displacement over time of the representative single QDot-SERT 
complexes in C. E, Plot of MSD/∆t as a function of ∆t of the representative single SERT 
proteins in C on a log-log scale. Single SERT under MCD treated condition shows the 
pattern expected of free diffusion whereas SERT from untreated cells demonstrates a 
pattern consistent with motion restriction, or anomalous subdiffusion. White, dashed 
lines in E represent a least squares best-fit of the data.  
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Figure 4.3 Single QDot-labeled SERT proteins demonstrate elevated SERT lateral 
mobility after membrane raft disruption.A, Distributions of the instantaneous 
displacement of single SERT proteins in control (black, n=52) and MCD treated (red, 
n=51) conditions. B, Comparison of instantaneous velocities of single SERT proteins in 
untreated and MCD treated RN46A cells. Each set of data was collected from 3 
independent experiments.  
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Figure 4.4 Characterization of the dynamic behavior of single SERT proteins. Plots of 
MSD/∆t as a function of ∆t and distribution of diffusion coefficient of single SERT 
proteins in control cells (A-B;n=98) and in MCD treated cells (C-D,n=91). A, B, 
Although the variability exists in both cases, the majority of SERT proteins in untreated 
cells display confined diffusion pattern with lower diffusion coefficient values. C, D,In 
contrast, single SERT proteins after MCD treatmentfollow free diffusion with higher 
diffusion coefficients. Black circles in A and red circles in C present the average MSD/∆t. 
Panels B and D were fit to double and single Gaussian distributions, respectively. 
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4.3.2 Single Qdot-Labeled SERT Proteins Demonstrate Increased SERT Lateral 
Mobility, Despite a Confined Distribution, after 8-Br-cGMP Treatment 
Although our direct observations, along with the chemical manipulation of RN46A 
cells, revealed inherent restrictions in the mobility of single, plasma membrane SERT 
proteins, such treatments do not address the degree to which mobility restrictions 
contribute to physiologically relevant features of transporter regulation. As noted above, 
SERT membrane trafficking and catalytic activity are under tight regulation by multiple 
signaling pathways2 that are affected by OCD and autism SERT mutations.6-9 Activation 
of PKG by cGMP analogs in both SERT-transfected and native SERT expressing, 
RN46A cells triggers SERT phosphorylation, enhanced SERT surface trafficking, and an 
increase in 5-HT uptake rates.2 Moreover, OCD- and autism-associated SERT coding 
variants display altered PKG-dependent SERT phosphorylation, trafficking and/or 
catalytic activation in vitro and in vivo.6-8, 35 We thus sought to determine whether PKG 
activation produces an altered motion behavior of SERT proteins localized to membrane 
subdomains. To investigate the above hypothesis, we compared the instantaneous 
velocity of single SERT proteins in control and 8-bromo cGMP (8-Br-cGMP) (a 
membrane-permeable cGMP analog that activates PKG) treated RN46A cells. 
Interestingly, we detected a significant, ~2 fold, increase in the mean instantaneous 
velocity after 8-Br-cGMP treatment (Fig. 4.5A) (1.60 ± 0.03 m/s versus 0.75 ± 0.06 
m/s, P<0.0001, Student’s t-test.). Additionally, when we performed diffusion coefficient 
analysis on 8-Br-cGMP treated cells, the distribution of SERT diffusion rates after 8-Br-
cGMP treatment still resulted in bimodal behavior (Fig. 4.5B), although a significant 
increase in higher diffusion rates was observed compared to the untreated cells (Fig. 
4.4B). 
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Figure 4.5 Effect of 8-Br-cGMP on SERT lateral mobility. A, Comparison of 
instantaneous velocities of single SERT proteins in untreated and 8-Br-cGMP stimulated 
cells. B, Distribution of diffusion coefficient of single SERT proteins (n=90) after 8-Br-
cGMP treatment and fit with double Gaussian distributions. C, Plots of MSD/∆t as a 
function of ∆t of single SERT proteins (n=90) in MCD treated cells are shown. Black 
circles and red circles show the average MSD/∆t of constrained (75.6%) and mobile 
(24.5%) population of single SERT trajectories. D, Comparison of instantaneous 
velocities of single SERT proteins in 8-Br-cGMP stimulated or 8-Br-cGMP plus 
SB203580 (SB) co-treated cells. Data derived from 3-6 independent experiments.  
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 The increase in SERT instantaneous velocity, accompanied by elevated diffusion 
rates, following 8-Br-cGMP treatment that are known to elevate SERT activity were 
surprising. As above, we noted that we increased SERT mobility accompanies MCD 
treatment that produce a reduction in SERT activity.10, 11 Furthermore, the anomalous 
exponent  derived from log-log plots (Fig. 4.5C) indicates that 75.6 % of SERT proteins 
in 8-Br-cGMP treated cells exhibit confined lateral diffusion, similar to the fraction (89.8 
%) observed with untreated cells. Thus, despite the observation that accelerated SERT 
movements are evident for a large fraction of SERT molecules following 8-Br-cGMP 
treatment, the majority of SERT proteins appear to remain highly constrained in 
membrane microdomains. 
 
4.3.3 The p38 MAPK Inhibitor SB203580 Attenuates 8-Br-cGMP Induced 
Enhancements in SERT Lateral Mobility 
 Treatment of RN46A cells with 8-Br-cGMP induces a PKG-dependent 
mobilization of intracellular SERT loaded vesicles, leading to an increase of SERT cell 
surface density.2 Since our QDot-SERT surface labeling paradigm should be insensitive 
to the trafficking of unlabeled intracellular SERT proteins to the cell surface, we suspect 
that the altered mobility of SERT proteins after 8-Br-cGMP treatment might relate to the 
transport rate enhancement (catalytic activation) of surface transporters that arises 
subsequent to PKG-stimulated membrane trafficking.2, 6 Previously, we showed that 
SERT catalytic activation arises as a result of PKG-triggered p38 MAPK activation that in 
turn stabilizes SERT in a conformation recognizing serotonin with higher-affinity.36, 37 
Therefore, we asked whether p38 MAPK activation is essential for the observed 
changes in SERT movements following 8-Br-cGMP treatment by co-incubating cells 
treated with 8-Br-cGMP with the specific p38 MAPK inhibitor SB203580. As shown in 
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Figure 5D, co-incubation of 8-Br-cGMP treated RN46A cells with SB203580 significantly 
attenuated the increase in SERT instantaneous velocity observed with 8-Br-cGMP alone. 
 To visualize better the displacements of single SERT movements following 
different treatments, we plotted lateral trajectories of single transporter movements over 
a 5 sec recording interval (d5S), comparing control, MCD, and 8-Br-cGMP treatments 
(Fig. 4.6A-C). Whereas instantaneous velocity is used to monitor the dynamic behavior 
at a relatively short timescale, 5 sec displacement measures provide an estimation of the 
extent of lateral movement, thereby estimating the borders of the membrane 
compartment occupied by single SERT proteins. As can be seen in Figure 4.5A-B, single 
SERT proteins in untreated cells displayed limited displacement, whereas the 
movements in MCD-treated cells exhibit significantly greater dispersal. Our results 
demonstrate that 8-Br-cGMP treatment (or 8-Br-cGMP/SB203580 co-treatment) 
generates SERT displacements that are indistinguishable from untreated cells when 
monitored at a longer timescale (Fig. 4.6C-D). Thus, cGMP-linked signaling pathways 
appear to enhance SERT activity without a dissociation of transporters from the 
membrane microdomains in which they were initially labeled. 
 
4.3.4 IL-1β Activated Single SERT Proteins Reveal p38 MAPK-Dependent 
Subpopulation 
Having linked increased mobility of SERT proteins within the membrane rafts to 
p38 MAPK-dependent pathways, we asked whether a natural stimulus that produces 
p38 MAPK-dependent SERT activation, independent of PKG, would reproduce the 
mobility changes induced by 8-Br-cGMP. We have shown that the inflammatory cytokine 
IL-1 acts through plasma membrane IL-1 receptors38 to produce a p38 MAPK-
dependent catalytic activation of SERT proteins in RN46A cells, as well as in brain 
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synaptosomes. As shown in Figure 4.6F, IL-1 treatment (100 ng/mL; 30 min; 37°C) of 
RN46A cells produces a rightward shift in the instantaneous velocities of single SERT 
molecules, in comparison to untreated cells, documenting enhanced transporter velocity. 
The distribution of velocities is well-fit to a model comprised of two populations: one 
aligned with the low mobility distribution that was observed under untreated conditions 
and a second aligned with the distribution previously described following 8-Br-cGMP 
stimulation. We also found that treatment with IL-1, like 8-Br-cGMP, caused an 
increase in the fraction of SERT molecules exhibiting accelerated velocity (Fig. 4.6F) 
with high diffusion coefficients (Fig.4.6G). As with 8-Br-cGMP treatment, the 2D 
displacements of single SERT molecules did not differ from that observed in untreated 
cells (Fig. 4.6E), and SERT remained localized to CTxB-labeled membrane 
microdomains. These results provide strong support that both 8-Br-cGMP and IL-1-
induced stimulation of SERT activity arises via a p38 MAPK-dependent mobilization of 
transporter proteins that remain confined to membrane microdomains. 
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Figure 4.6 p38 MAPK-dependent increase in SERT mobility in the absence of lateral 
dispersion. A-E, 2D Polar plots of 5 sec displacements (d5s) of single SERT movements, 
normalized to their starting coordinates under control, MCD, 8-Br-cGMP, 8-Br-cGMP 
plus SB203580, and IL-1 treated conditions, respectively. Plots provide data in pixel 
units (200 nm/pixel). Data were collected from 3-6 independent experiments with 90-100 
trajectories for each condition. F, Comparison of instantaneous velocities of single SERT 
proteins in untreated and IL-1 stimulated cells. The best-fit velocity distribution of IL-1 
treated SERT proteins reveals a dominant population (76.9 %) with higher velocities and 
a minor population (23.1%) with lower velocities. G, Distribution of diffusion coefficient of 
single SERT proteins (n=99) after IL-1 treatment (double Gaussian fit). 
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4.3.5 Cytoskeletal Disruption Mobilizes SERT Molecules That Remain Confined to 
Membrane Microdomains  
A possible mechanism responsible for confined diffusion of SERT proteins in 
membrane microdomains, and one that could be a target for p38 MAPK regulation 
associated with transporter activation, is the liberation of transporters from 
juxtamembrane cytoskeletal networks  that could confine movements of raft-localized 
transporters.2 To determine whether SERT lateral mobility within these domains is 
restricted by cytoskeletal interactions, we treated cells with the actin filament disrupter 
cytochalasin D (CytoD) (0.5 g/ mL; 30min; 37°C) a dose that does not produce gross 
changes in cell morphology. Like 8-Br-cGMP and IL-1 treatments, this treatment 
produced a bimodal distribution of diffusion rates for single QDot-labeled SERT 
molecules (Fig.4.7), with an increased representation of the more mobile population. 
CytoD treatment produces an increase in diffusion rates for both subpopulations, as 
compared to 8-Br-cGMP and IL-1 treatments (fitted Gaussian center D value: relative 
immobile population increases from (1.32  0.04)10-3 to (1.05  0.03)10-2m2/s; 
relative mobile population increases from (2.63  0.04)10-2 to (6.92  0.01)10-2m2/s), 
consistent with a contribution of cytoskeletal interactions also constraining SERT lateral 
mobility to some degree outside of lipid rafts. Compared to untreated cells, the 
instantaneous velocity of single QDot-labeled SERT proteins from CytoD treated cells 
was significantly elevated (Fig. 4.8A), with 93% of the transporters fit to a higher velocity 
component (1.51  0.06 m/s vs 0.75 ± 0.06 m/s for untreated cells). We found very 
similar results in monitoring the instantaneous movements of membrane rafts using 
single QDot-labeled GM1/CTxB complexes following the same CytoD treatment (Fig. 
4.8B). However, CytoD treatment did not disperse CTxB labeling as seen with MCD 
treatment, consistent with an actin-independent contribution to microdomain integrity. 
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Importantly, SERT proteins remained colocalized with CTxB/GM1 (Fig. 4.7B). When IL-
1 (100 ng/mL; 30 min; 37°C) was added to cells pretreated with CytoD, no further 
increase in SERT velocity was achieved (Fig. 4.8C). We do not believe that this is a 
ceiling effect on velocity as MCD treatment increase rates beyond this level (higher 
velocity component: 1.82  0.06 m/s, Fig. 5A +8-Br-cGMP data fit with double 
Gaussian). Together, these data support the hypothesis that IL-1 activation of SERT 
arises as a result of the release of transporters from cytoskeleton-associated anchors, 
though the transporters remained trapped within membrane microdomains. 
SERT is known to associate through N and C-terminal cytoplasmic domains with 
multiple integral membrane and cytosolic proteins, several of which have been 
suggested to coordinate SERT regulation via cytoskeletal interactions.2, 39 In this regard, 
the SERT C-terminus has been shown not only to complex with integrins and integrin-
associated proteins that interact dynamically with the cytoskeleton5, 40 but also to interact 
with the PKG-linked signaling molecule nitric oxide synthetase (NOS).39 To determine 
whether SERT C-terminal protein interactions could account for microdomain-restricted 
mobility of transporters, we incubated RN46A cells with membrane permeate TAT-C-
terminal SERT peptides (C-SERT peptide) prior to single QDot-SERT tracking. As seen 
with IL-1β treatment, C-SERT peptide treatment generated a shift of the distribution to 
more rapid transporter diffusion rates (Fig.4.9A). In contrast to the untreated RN46A 
cells (Fig. 4.4B), TAT-conjugated SERT peptide derived from sequences upstream of 
those of the C-terminal SERT peptide (interior or U-SERT peptide) produced a similar 
SERT diffusion rate distribution (Fig. 4.9B) to that of untreated cells (Fig. 4.4B). 
Importantly, and as with IL-1 treatment, the C-SERT peptide produced an increase in 
SERT transport activity (Fig.4.9C). 
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Figure 4.7 Cytoskeletal disruption mobilizes SERT molecules that remain confined to 
membrane microdomains. A, Increased lateral diffusion of QDot labeled SERT proteins 
after CytoD treatment. Data fit with double Gaussian distributions. B, Retention of SERT 
proteins within membrane rafts in CytoD-pretreated RN46A cells. Upper left: DIC image; 
Upper right: staining of membrane rafts using Alexa 488-conjugated CTxB; Lower left: 
QDot-SERT proteins; Lower right: colocalization of CTxB and QDot labeling. 
Arrowheads denote the presence of multiple puncta labeled for both markers. 
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Figure 4.8 Actin cytoskeleton restricts SERT mobility within membrane microdomains in 
a p38 MAPK and SERT C-terminus dependent manner. Plots of instantaneous velocity 
of A, single QDot-labeled SERT proteins in RN46A cells treated with CytoD, B, single 
QDot-labeled GM1/CTxB complexes in RN46A cells treated with CytoD, C, single QDot-
labeled SERT proteins in RN46A cells treated with CytoD after IL-1β stimulation, and D, 
single QDot-labeled SERT proteins in RN46A cells treated with C-SERT peptide. Each 
condition represents results of three independent experiments. 
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Figure 4.9 Dissociation of SERT C-terminus from cytoskeletal-associated proteins 
creates increases in single SERT diffusion and SERT transport activity.A-B, Distribution 
of diffusion coefficient of single SERT proteins after C-SERT A and U-SERT B peptide 
treatments and fit with double Gaussian distributions. Data collected from five 
independent experiments. C, SERT activity in RN46A cells after U-SERT peptide 
treatment. SERT activity was monitored using the fluorescent monoamine transporter 
substrate IDT307 (see Materials and Methods). Data shown are representative of time-
lapse microphotographs (right) and fluorescent quantification (P < 0.01, Student’s t-test) 
(left) obtained in three independent experiments.  
  
89 
 
4.4 Discussion 
 Here we provide evidence that single QDot-labeled, plasma membrane-
embedded SERT proteins distribute between freely mobile pools and relatively immobile, 
cholesterol-rich microdomains where restricted mobility is derived from C-terminal 
interactions with the actin cytoskeleton. Our findings, which to our knowledge are the 
first to describe the mobility of single transporter proteins, were achieved by fusing the 
single molecule detection capacity of QDots to the specificity and high affinity of a 
pharmacological probe. The linker between the SERT antagonist and the SA-QDots was 
developed to provide both access of the ligand to its high-affinity binding site that lies 
midway through the plasma membrane41 and to enhance linker solubility. Although 
multiple biotin binding sites are theoretically available on the SA-QDots, the surface 
density of SERT proteins is very low on RN46A cells,38 and we used subsaturating 
concentrations of ligand as well as low concentrations of QDots to minimize multivalent 
labeling.20 Importantly, our antagonist-conjugated SA-QDots do not limit our ability to 
detect free diffusion kinetics of a subpopulation of SERT molecules nor to detect 
regulation of SERT through cGMP and p38 MAPK-linked pathways. Previously, we 
achieved population detection of SERT,17, 25 GABA receptor,42 and dopamine transporter 
(DAT)43 proteins using ligand-conjugated QDots. With respect to the prior SERT study, 
these efforts involved direct conjugation of 5-HT to QDots, prior to the application of this 
complex to cells. In subsequent studies, we found this approach to be of insufficient 
sensitivity and reliability for the detection of transporters on natively-expressing cells, 
due to the lower affinity of 5-HT, the higher nonspecific binding of the QDot conjugate, 
and the stability of the QDot complexes after binding. Nonetheless, our success in these 
efforts provided critical evidence that a modification of this approach could be 
generalized and enhanced to achieve detection of SERT diffusion dynamics. Many more 
small molecule ligands, including therapeutic compounds, are available that target 
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membrane proteins rather than surface-epitope antibodies, and thus the methods 
presented here appear well-suited to the detection of other receptors, ion channels and 
transporters targeted by widely available pharmacological tools and medications. 
 In our report, we establish that SERT instantaneous velocity is significantly 
enhanced by both chemical depletion of membrane cholesterol and activation of p38 
MAPK-dependent signaling pathways, two manipulations that exert opposite influences 
on SERT activity. In resolving this puzzle, we discovered a previously unsuspected 
correlation of SERT activation involving the mobilization of transporters from 
juxtamembrane tethers within cholesterol-rich microdomains. Importantly, mobilized 
transporters do not leave these membrane microdomains, providing a mechanism for 
reversibility of associations that can both increase and decrease surface-resident SERT 
proteins.Membrane cholesterol has been reported to have a varied effect on the 
diffusion of surface proteins.11, 44 Cholesterol extraction using MCD increases the 
diffusion coefficient of dopamine transporter populations assessed by fluorescence 
recovery after photobleaching (FRAP).28 In contrast, extraction of membrane cholesterol 
results in plasma membrane changes that reduce diffusion of MHC II proteins.45 The 
degree to which SERT protein function in vivo depends on membrane cholesterol is 
unknown, though one advantage to our in vitro studies is the use of a serotonergic 
neuronal model that expressed endogenous SERT proteins, limiting potential artifacts 
due to heterologous expression. Human clinical studies report inconsistent findings on 
the impact of reduced cholesterol and/or cholesterol-lowering therapy risk for mood 
disorders or their treatments.46, 47 Interestingly, a recent study in rats demonstrated that 
lovastatin treatment enhances the ability of the SERT-directed antidepressant fluoxetine 
to reverse despair behavior,48 findings that should be investigated to determine whether 
they reflect, at least in part, alterations in SERT membrane dynamics. Additionally, 
antidepressant drugs have been reported to concentrate in membrane microdomains49 
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and whether this partitioning might influence SERT membrane dynamics as well as 
block re-uptake should be explored. Finally, we have shown recently that A3 adenosine 
receptors physically associate with SERT and regulate SERT catalytic function in 
RN46A cells via p38 MAPK.50 Our results are most consistent with this regulation being 
highly localized and provide an explanation for how signaling pathways that act on many 
other targets within the cell can be limited to specific targets, in this case toward SERT.  
 What molecular mechanisms support the single molecule findings associated 
with p38 MAPK-dependent SERT regulation? SERT is known to reside in 
macromolecular complexes whose composition changes as a function of regulatory 
stimuli.2, 50 The association of several proteins with SERT can be altered by stimuli that 
influence SERT activity, including syntaxin 1A and the focal adhesion interactor Hic-5.5, 
51 Hic-5 is a focal adhesion-associated protein known to associate with both the SERT 
C-terminus and the actin-rich, membrane cytoskeleton. We have shown that Hic-5 
addition to resealed membrane vesicles in vitro reduces SERT activity.5 Furthermore, 
SERT/Hic-5 associations are enhanced by stimuli, such as PKC activation, that lead to 
initial SERT catalytic inactivation and subsequent internalization. Therefore, we 
hypothesize that the orchestrated dissociation from the SERT C-terminus of 
cytoskeletal-associated proteins, such as Hic-5, places the transporter in a more active 
conformation, and that such dissociation accounts for both the increase in SERT mobility 
we observed and the increase in SERT activity found upon manipulation of SERT 
cytoskeletal interactions (Fig. 4.10). In support of this idea, Hong and Amara have 
recently provided evidence that cholesterol-rich microdomains favor an outward facing 
conformation of DAT52 and we have previously shown that activation of p38 MAPK 
enhances the affinity of the transporter for 5-HT.37 
 To conclude, we show here that the diffusion rate distribution of single QDot 
labeled SERT proteins under control, 8-Br-cGMP, and IL-1β treated conditions exhibit a 
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bimodal distribution, with populations exhibiting higher rates of mobility increased after 8-
Br-cGMP (Fig. 4.5B) and IL-1β (Fig. 4.6G) treatments. These changes in mobility are not 
the same as those generated through cholesterol depletion and elimination of membrane 
rafts, which also reduce SERT activity. Importantly, the actin cytoskeleton and the SERT 
C-terminus appear to play critical roles in the mobilization of SERT within these 
membrane microdomains. Thus, we believe that a major aspect of SERT regulation 
relies on a tightly controlled, and dynamic, cytoskeletal interaction (Fig. 4.10). The ability 
of Il-1β to stimulate SERT mobility places our findings in a physiological context, given 
that our findings that this receptor regulates SERT activity in vitro and in vivo,38, 53 and is 
consistent with prior findings that Il-1 signaling arises from raft-like membrane 
microdomains.54 Finally, we hypothesize that OCD and autism-associated SERT 
mutations that are known to constitutively enhance SERT activity and to disrupt PKG 
and p38 MAPK-dependent regulation6, 9 derive their pathophysiological impact from 
perturbed SERT cytoskeletal associations in membrane microdomains. 
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Figure 4.10 Model for SERT-cytoskeletal interactions dictating cell surface transporter 
regulation. In the resting state, SERT is present in two compartments, one that permits 
free diffusion in the membrane (left), and a second compartment that represents 
confinement to membrane microdomains (center) where transporters are immobilized by 
cytoskeleton-associated proteins (middle). When cytoskeleton-associated constraints 
are relaxed in response to PKG/IL-1β/p38 MAPK activation (or through actin 
destabilizers or C-SERT peptide treatments), SERT remains confined to membrane 
microdomains (right), though now transporters can adopt conformations that favor 
increased transport activity. Question mark overlying transitions into and out of 
membrane microdomains denotes the possibility that such movements could also play a 
role in SERT regulation, though they are not features of the PKG and p38 MAPK-
dependent SERT regulation detected in the current study. 
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CHAPTER 5 
 
Summary and Future Perspective 
 
5.1 Introduction 
 Plasma membrane, the physical barrier of the smallest living unit, a single cell, 
consists mainly of bilayer phospholipids with embedded proteins. It not only allows for 
accomplishing vital biological functions but also governs the movement of materials and 
signals in and out of the cell. For the past four decades, the most well-known model of 
plasma membrane is the fluid mosaic model,1 in which the membrane proteins are 
viewed as freely floating boats in the phospholipid "sea." However, recent investigations 
have found that the diffusivity of cellular membranes in eukaryotes has fewer degrees of 
freedom as was predicted in the fluid mosaic model, suggesting the regulatory role of the 
surrounding lipid environment in membrane signaling/interaction.2 It has become 
increasingly clear that the cell membrane is far from homogeneous but contains various 
small microdomains for specialized functions.2-4 In many cases, the cholesterol-enriched 
membrane microdomains, also known as lipid rafts, were indicated to participate in 
cellular signaling by providing the microenvironment necessary for complex protein-
protein interactions.4, 5 In addition, recent biochemical studies demonstrated a 
connection between membrane microdomains and the cytoskeleton. This connection 
found to influence membrane compartmentalization,2, 5 further suggests the role of 
membrane microdomains in the secretary and endo-exocytotic pathways. Together, 
these largely underdeveloped properties explain the recent emergence of the studies in 
membrane dynamics and vesicle trafficking. 
 To date, various techniques based on optical microscopy have been created to 
allow observation and quantification of membrane dynamics. These approaches can be 
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generally categorized into two groups based on the collected data types: the first group, 
such as fluorescence recovery after photobleaching (FRAP) and conventional 
immunofluorescence microscopy, is developed to depict the ensemble average 
response of the movement of fluorescently labeled molecules; while the second, known 
as single molecule microscopy, is designed to extract diffusion parameters from probing 
multiple single events.6 The ensemble-averaging approach, although convenient and 
widely used, presents an obvious disadvantage regarding the representativeness of the 
experimental data: the lost of sub-population distribution in the ensemble average.6 To 
characterize the diffusion rates in different domains of the plasma membrane, the single-
molecule tracking (SMT) approach is clearly a better choice.2 The basis of SMT is to 
follow the real-time movement of individual biological targets using high-speed 
fluorescent microscopy (typical time resolution: 10-100 milliseconds) with high spatial 
resolution (at the nanometer scale), resulting in a map of the real-time dynamics upon 
observing many individual events. Based on the above definition, an ultimate sensitivity 
is required, which allows individual single molecules to be monitored in a picoliter- to 
femtoliter-sized microscope sampling volume. A fundamental limit is, however, subject to 
Abbe's optical diffraction limit, which is  250 nm in the visible spectrum. To achieve a 
sub-pixel localization in SMT, the FIONA (Fluorescence Imaging with One-Nanometer 
Accuracy) approach is typically performed (Figure 5.1).7 Single emitters viewed through 
a microscope produce an Airy disc diffraction pattern in the image plane. In the FIONA 
approach, this pattern is analyzed in terms of the point spread function (PSF) where the 
localized centroid is determined by fitting the PSF to a 2-D Gaussian profile with a least-
squares estimator: 
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, where Ixy is the intensity of the pixel, 0x  and 0y  is the designated local maximum 
coordinates of the Gaussian, A is the amplitude of the signal with local background A0, 
and w is the width of the Gaussian curve. It is important to note that the coordinate ( 0x ,
0y ) acquired by fitting function [1] is not a true position but only an estimate; the 
accuracy is strongly dependent upon the respective signal-to-noise ratio (SNR), which is 
defined as: 
 0
0
2 2
bg I
ISNR     [2] 
, where 0I  is the maximum signal intensity above background, 
2
bg  is the variance of the 
background intensity values, and 2
oI
  is the true variance of the maximum signal 
intensity above the background. However, common organic fluorophores used in single-
molecule imaging have a very limited photon yield and a narrow Stokes shift(the 
difference between excitation and emission wavelengths), which makes them difficult to 
produce a sufficient SNR for single molecule imaging. In addition, photobleaching 
associated with organic fluorophores prevents their usefulness in long-term monitoring. 
Hence, these shortcomings associated with organic fluorophores places a high demand 
for new fluorescent materials for single-molecule tracking. 
 Fluorescent quantum dots (QDots) are semiconductor nanomaterials with a size 
in the range of 2-10 nanometer, smaller than their Bohr exciton radius, which makes 
QDots display discrete, quantized energy levels. Extraordinary optical properties in 
QDots include high quantum yield, broad adsorption with monochromatic narrow 
emission, high molar extinction coefficients, and a large Stokes shift (for review, see 
Rosenthal et al.8).Over the past decade, QDots have been popularly used in biological 
labeling applications (for review, see Chang et al.9). As mentioned, the sub-pixel 
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localization in single molecule imaging is dependent upon the SNR, which is highly 
correlated to the total photons emitted and the Stokes shift of a single emitter. Unlike 
conventional fluorescent dyes, these two properties make QDots much more 
advantageous. Additionally the superior photostability makes QDots particularly useful 
for long-term tracking studies (minutes to hours). Since its emergence in the biological 
imaging field, single QDot imaging approach has played an essential role in investigating 
cellular signaling and regulation. In the following sections, we highlight recent biological 
applications using single QDot techniques, in particular the applications in exploring 
membrane dynamics and intracellular trafficking. 
 
 
Figure 5.1 Schematic representation of the diffraction pattern from a point emitter 
passed through an optical device.(A) Owing to diffraction, the smallest distance to which 
an imaging system can optically resolve separate light sources is limited by the size of 
the Airy disk. (B) Fitting a 2D Gaussian function to the PSF of a single emitter yields 
nanometer precision, termed Fluorescence Imaging with One Nanometer Accuracy 
(FIONA). Adapted from reference (7). 
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5.2 Mapping Receptor Membrane Diffusion 
By utilizing the superior fluorescent properties of QDots and a highquantum-
efficiency back-illuminated electron multiplying charge-coupled device (EMCCD) camera, 
Dahan et al. first reported the use of single QDot imaging approach to investigating 
endogenous glycine receptors (GlyR) at the surface of cultured rat spinal cord neurons.10 
Importantly, the authors were able to characterize multipleGlyR diffusion domains in 
relation to the synaptic, perisynaptic, and extrasynaptic GlyR localization, which was 
unable to be determined by conventional ensemble methods. Since then, several studies 
inspired by this work are directed toward addressing the specific biological functions of 
membrane protein sub-populations. 
 In line with the above study, noticeable efforts in single QDot approach were 
made in recent years on the studies of the cholesterol and ganglioside GM1-enriched 
membrane microdomains.4 Pinaid et al. developed a raft-associated glycosyl-
phosphatidyl-inositolanchored avidin test probe (Av-GPI) to study the correlation 
between the diffusion of individual Av-GPI and the location of GM1-rich microdomains 
and caveolae in the transfected HeLa cells.11 Single QDot-labeled Av-GPI complexes 
were found to exhibit dynamical partition in and out of GM1-rich microdomains in a 
cholesterol-dependent manner. In a native, non-transfected neuronal cell line, we used 
single QDot-labeled cholera toxin B subunit (CTxB) to investigate the diffusion dynamics 
and membrane compartmentalization of the GM1-rich microdomains.12 Diffusion 
measurements revealed that single QDot-labeled CTxB-GM1 complexes undergo slow, 
confined lateral diffusion with a diffusion coefficient of ∼7.87 × 10−2 μm2/sec and a 
confinement domain about 200 nm in size. Further analysis of the trajectories showed 
lateral confinement persisting on the order of tens of seconds, comparable to the time 
scales of the majority of cellular signaling and biological reactions. 
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 The importance of lipid rafts in membrane protein signaling and regulation was 
also tested with the single QDot approach. In a recent publication, we reported the first 
use of ligand-conjugated single QDots for the investigation of membrane dynamics of 
serotonin transporter, a primary target for antidepressant medications.13 Two types of 
subpopulations of SERT were found in living neuronal cells: one exhibits relatively free 
diffusion and the other localize to cholesterol and GM1 ganglioside-enriched 
microdomains, which displays restricted mobility. Disruption of membrane rafts by gentle 
cholesterol depletion results in an increase of single SERT mobility and a loss of SERT 
confined diffusion (Figure 5.2). In addition, mobilization of transporters arises from a p38 
MAPK-dependent untethering of the SERT C-terminus from the juxtamembrane actin 
cytoskeleton. This study demonstrates the potential of ligand-conjugated QDots for 
analysis of the behavior of single membrane proteins in relation to critical cellular 
signaling and regulation. 
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Figure 5.2 Single QDot-SERT tracking in living serotonergic RN46A cells under 
control and lipid raft-disrupted conditions. (A) Temporal profile of representative 
QDot-labeled, single SERTs with and without lipid raft disruption. Note the more 
mobile behavior of the single QDot after lipid raft disruption. (B) Comparison of 
the mean squared displacement over time of the representative single QDots in 
(A). Single SERT under a lipid raft-disrupted condition shows the pattern 
expected of free diffusion whereas single SERT from untreated cells 
demonstrates a pattern consistent with confined lateral diffusion. Adapted from 
reference (13). 
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5.3 Endosomal Trafficking and Endocytosis 
 Endosomal trafficking and endocytosis are known to be highly heterogeneous in 
space and time. However, it is a challenging field of research due to technical difficulties 
of visualizing the processes in real-time. Cui et al. presented a milestone study in which 
the real-time movement of nerve growth factor (NGF) axonal transport was followed with 
single QDot imaging approach in live rat dorsal root ganglion (DRG) neurons.14 To 
achieve a monovalent presentation of NGF dimer on the QDot surface, a stoichiometric 
ratio of NGF to QDot of 1:1.2 was adapted in their conjugation procedure. In a clever 
setup, NGF–QDot conjugates were first added to the microfluidic chamber containing 
distal axons of DRG neurons and allowed to bind and form complexes with NGF 
receptors and undergo subsequent internalization into early endosomes. Interestingly, 
endosomes containing NGF–QDots were found to exhibit ‘stop-and-go’ retrograde 
transport toward the neuronal cell body with an average speed of 1.31 ± 0.03 μm/sec 
(Figure 5.3A). The presented research also underscores the potential utility of single 
QDot nanoconjugates for intracellular applications as the real-time observation of 
intracellular endosome movement is achieved in this study. 
The same technique, with emphasis on the internalization measurement, was 
successfully extended by Fichter et al. to quantify the endocytosis of G-protein–coupled 
receptors (GPCRs), the biggest protein superfamily and the major drug targets.15 In this 
study, a small group of 5-HT1A receptors, a type of metabotropic G protein-coupled 
receptors, were labeled with single QDots and, importantly, the authors found that single 
QDot probes do not interfere with the internalization kinetics of receptors in live cells. In 
their analysis, sustained 5-HT exposure elicited receptor internalization that increased 
from 20 to ∼ 60 – 70 % within 60 min, indicating sustained receptor internalization in 
response to continuous 5-HT stimulation (Figure 5.3B). Further research may allow for 
elucidating the actions of GPCR-targeted therapeutics. 
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Figure 5.3 Single QDot imaging for endosomal trafficking and endocytosis(A) Live 
imaging reveals that single QD-NGF containing endosomes exhibit stop-and-go motion. 
Left: A typical axon showing four moving endosomes that contained QD-NGF in 
pseudocolor. Center: Trajectory of a typical endosome, showing a switch between 
moving and pausing. Right: Trajectories of 120 endosomes showing that the moving 
speed and the duration of pauses vary greatly from one endosome to another. Adapted 
from reference (14). (B) Cellular internalization of single QDot-labeled serotonin receptor 
complexes during continuous serotonin stimulation in transfected N2a cells. Red: QDot 
probe; green, plasma membrane, visualized with DiO. The scale bar is 10 m. Adapted 
from reference (15). 
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5.4 Dynamic Processes of Intracellular Targets 
Recently, several groups came up with brilliant ideas to take advantage of the 
nanoscale sized single QDots as a “molecular ruler” in measuring the dynamics of 
intracellular processes. In an exciting example, Zhang et al. used single QDot 
fluorescence to investigate the molecular mechanism of vesicular secretion of 
neurotransmitters in the living neurons.16 Since a single synaptic vesicle is so small 
(lumen diameter ∼ 24 nm) that it can only load one QDot (~ 15 nm) at a time, the 
authors used single QDot imaging to see if a full-collapse fusion (FCF) or a kiss-and-run 
fusion (K&R) is taking place during neuron firing; the former refers to a preloaded single 
QDot being released, while the latter depicts the single QDot being trapped in the vesicle. 
In addition to the size of the QDots, the authors also cleverly took advantage of another 
important character of single QDot, the pH-dependent fluorescence fluctuation, where 
the author found that the QDot fluorescence would increase by ∼ 15% if the single 
QDots move from intravesicular space (pH ~ 5.48) to extracellular space (pH ~ 7.34). As 
such, in the K&R one could only capture the increase of QDot fluorescence but not the 
escape of QDot, while in the FCF similar Qdot brightening would appear followed by a 
complete loss of signal as the QDot escaped from the synaptic vesicle. Using this 
sophisticated yet elegant approach, a stochastic vesicle dynamic is established in which 
the authors successfully correlate the increased neurotransmitter release probability with 
a higher prevalence of K&R. 
 Another excellent example under this category is the use of peptide-conjugated 
QDots as a cargo to investigate the intracellular nuclear transport via nuclear pore 
complex (NPC).17 It is known that NPC acts as the gatekeeper for traffic into and out of 
the nucleus. Unlike small molecules which can passively diffuse through NPC, the 
transportation of larger protein-based cargo into nucleus requires a dedicated transport 
mechanism. Generally the signal-dependent nuclear transport is facilitated by 
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nucleoplasmic shuttling receptors of the importins/karyopherins, which are associated 
with Ran GTPase. In the study reported by Lowe et al., the authors conjugated the 
importin-β binding domain to QDots (IBB-QDot) and used single IBB-QDots as pseudo 
cargos to visualize the nuclear translocation process (Figure 5.4).17 Additionally, the 
conjugated IBB-QDot complexes have a mean hydrodynamic diameter of 18 ± 4 nm, 
similar to the size of native cargos that translocate into nucleus via receptor-driven 
transport through NPC. Remarkably, with the precise single QDot imaging analysis the 
authors were, for the first time, able to calculate the multi-step processes of Ran 
GTPase-dependent importthrough NPC:cargo capture (25% success rate), filtering and 
translocation (80% success rate), and cargo release into the nucleus (50% success rate 
with Ran; > 99% abort without Ran).  
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Figure 5.4 Characterization of nucleocytoplasmic transport with single QDot approach. 
(A) Diagram of QDot-based cargo. The snurportin-1 IBB/Z-domain fusion protein is 
coupled via a bifunctional SMCC crosslinker to the amino-PEG polymer coat of a 
fluorescent QDot. The three helix Z-domain acts as a spacer to correctly present the IBB 
for biological function. (B) Dynamic light scattering size distributions of QDot-IBB cargos 
in the presence and absence of importin-β. (C) Dwell time distribution of all QDot 
interactions with the NPC. The time axis is truncated at 300 sec. (D) Bright-field image of 
a nucleus with a QDot fluorescence image (with background subtraction applied) 
overlaid in red. A single QDot cargo at the nuclear envelope is boxed. (E) Individual 
consecutive frames from a single-molecule experiment showing the arrival (first frame) 
from the cytoplasm and departure (final frame) of the cargo into the nucleus. The 
centroids determined from the fitting of the PSF are overlaid as red crosses. Frame 
numbers are at the bottom left hand corner of each frame. Movies were captured at 40 
Hz. Adapted from reference (17). 
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5.5 Single-Quantum Dot FRET 
 Fluorescence resonance energy transfer (FRET) is a photophysical process 
where the excited-state energy from a donor fluorophore can be non-radiatively 
transferred to a nearby acceptor fluorophore. The energy transfer is through a dipole-
dipole coupling and the obtained distance has to be in the range of 1-10 nm (for a review 
of FRET principle, see Selvin18). Since the initial works of Willard et al.19 and Medintz et 
al.20 demonstrating the potential of QDot as a FRET donor for biosensing, similar 
concepts have been applied to various biological applications such as explosive 2,4,6-
trinitrotoluene (TNT) detection,21 proteolytic activity assay,22-25 and molecular sensing of 
microenvironmental changes in pH,26, 27 and calcium ions.25 
The bottleneck in single molecule FRET studies is the low SNR. However, with 
the assistance of high SNR QDot probes Zhang et al. first developed a FRET-based 
single QDot nanosensor for specific nucleic acid detection (Figure 5.5).28 A sandwich-
type hybrid structure was designed to detect the target sequence by the presence of a 
biotin-labeled capture probe and a Cy5 labeled reporter probe. The hybridized sequence 
assembly then self-assembles on the streptavidin-conjugated QDot and thus forming a 
FRET donor–acceptor ensemble. Extremely high femtomole sensitivity was achieved in 
this study. This is about 100 times higher than the molecular beacon approach, the gold 
standard FRET method for nucleic acid detection. However, we wish to note that, 
despite various successes in molecular sensing, single QDot FRET probes are mostly 
limited in biochemical assays. To the best of our knowledge, studies have not yet been 
revealed to demonstrate live cell imaging applications. 
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Figure 5.5 Single QDot-FRET for DNA detection (A) Conceptual scheme showing the 
formation of a single-QDdot based DNA nanosensor in the presence of targets. The 
resulting assembly brings the fluorophore acceptors and the QDot donor into close 
proximity, leading to energy transfer from QDot to acceptors. (B) Representative traces 
of fluorescent bursts detected with QDot nanosensors. Fluorescent signals are acquired 
by both the donor and the acceptor detectors. In the presence of targets, fluorescent 
bursts were detectable in both donor and acceptor detectors. When targets were absent, 
fluorescent bursts were only detected by the donor detector, not by the acceptor detector. 
Adapted from reference (28). 
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5.6 3-D Single Quantum Dot Tracking 
While the application of live cell 3-D single QDot tracking is still in its infancy, 
recent advances in ultrasensitive detectors, in particular the high-speed ultrasensitive 
EMCCD cameras, offer great promise in this field. Two common approaches have been 
taken toward the construction of 3-D single QDot trajectories in real-time. Thefirst is to 
conduct multifocal plane imaging with a widefield fluorescent microscope. Photons 
generated from a targeted single QDot are split into multiple paths. In each light-path, 
the signal is turned at a specific calibrated distance that allows each detector to only 
reflect a specific focal plane (z) information.29 An obvious advantage of this technique is 
to simultaneously track multiple focal planes over a large z-range, which enables the 
observation of whole cell events in real-time. By simultaneous projecting single QDot 
position into 4 EMCCD cameras, a recent report from Ram et al. demonstrated an 
amazing 10 micron z-range in 3-D single QDot tracking of the transferrin receptor in a 
live epithelial cell monolayer.29 Although this approach is relatively straightforward and 
effective, it requires multiple high-end EMCCD cameras, which may not be a preferred 
method for general laboratory use from a cost-effectiveness point of view. 
A different kind of 3-D tracking approach, which also uses a widefield fluorescent 
microscope, is aimed at 3-D localization from a single detector. An outstanding example 
established by the Moerner Lab is to engineer the PSF of a single emitter through a 
spatial light modulator.30, 31 This enables the display of additional Z-directional 
information on a single detector, where the single emitter exhibits two lobes in the image 
plane that rotate continuously around the optical axis with propagation, terms “double-
helix point spread function (DH-PSF)” (Figure 5.6A).In a recent study with the DH-PSF 
based 3-D fluorescent microscopy, Thompson et al. reported a nanometer localization 
accuracy along the x, y, and z directions, which allows following 3-D movement of a 
single QDot-labeled structure inside a living cell.31 Interestingly, the 3-D single QDot 
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trajectory showed a variety of diffusive and linear transport characteristics in live cells 
(Figure 5.6B), which would be otherwise missing if processed with 2-D tracking. 
 
 
Figure 5.6 3-D single QDot tracking with DH-PSF imaging approach. (A) schematic of 
the DH-PSF imaging system. L1 and L2 are focal-length-matched achromatic lenses, 
and SLM is a liquid crystal spatial light modulator. Bottom images are a bead emitting on 
average 2000 photons/frame shown at five different axial positions (from left to right -960, 
-510, -20, 510, and 970 nm). Scale bar is 1 µm. (B) 3-D plot of a single QDot trajectory in 
live COLO205 cells, showing a variety of diffusive and linear transport characteristics. 
Adapted from reference (31). 
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5.7 Conclusion and Future Perspective 
 Since the first demonstrations in biological imaging, water-soluble QDots have 
become popular probes for various biological imaging and detection applications.32, 33 
Their unique photophysical properties render them particularly valuable for revealing 
dynamic biological processes. However, owing to the size and the surface chemistry, 
even single QDots can cause multivalent binding, which is a major drawback in regards 
to QDots for single molecule studies.34 Recently, the preparation of monovalent QDots 
was demonstrated by Howarth et al., where each compact QDot was bound to only a 
single copy of monovalent streptavidin to enable the monovalent QDot-receptor labeling 
in living cells.35 Without a doubt, if commercially available, this material will find many 
applications in the field of single QDot imaging. 
Additionally, the pros and cons of QDot blinking in single QDot imaging have 
been previously discussed in great detail.36 On one hand, this property is popularly used 
as a criterion for identifying single QDots in live cells.10-17 On the other hand, it raises 
concern on the discontinuous trajectory of a single QDot tracking approach due to the 
temporary disappearance of the target position from the blinking events.37 We would like 
to indicate that the synthesis of non-blinking QDots based on a multishell approach38, 39 
and gradient alloyed core/shell structure37 were recently reported. Researchers are 
currently taking advantage of the non-blinking QDots in single QDot tracking 
experiments.40 We can expect the biological applications of non-blinking QDots to 
increase. 
 In summary, the biological applications of QDots have moved from a simple 
alternative to fluorescent dyes to more specialized topics for advanced biological 
research. This is particularly obvious in the cases of the recent development in single 
QDot applications. Although there are some limitations due to the physical nature of the 
QDots, advances in QDot synthesis and surface chemistry show significant potential to 
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eliminate these pitfalls. Considering the applications of a single QDot approach in the 
past few years, we are optimistic that the use of single QDots will largely advance our 
understanding in the biological research field. 
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Appendix A 
 
QUANTUM DOT DISPLACEMENT ASSAY FOR ANTIDEPRESSANT DRUG 
SCREENING 
 
A.1 Abstract 
 The serotonin (5-hydroxytryptamine, 5-HT) transporter (SERT) protein plays a 
central role in terminating 5-HT neurotransmission and is the most important therapeutic 
target for the treatment of major depression and anxiety disorders. We report an 
innovative, versatile, and target-selective quantum dot (QDot) labeling approach for 
SERT in single Xenopus oocytes that can be adopted as a drug-screening platform. Our 
labeling approach employs a custom-made, QDot-tagged indoleamine derivative ligand, 
IDT318, that is structurally similar to 5-HT and that accesses the primary binding site 
with enhanced human SERT selectivity. Incubating QDot-labeled oocytes with 
paroxetine (Paxil), a high affinity SERT-specific inhibitor, showed a concentration- and 
time-dependent decrease in QDot fluorescence, demonstrating the utility of our 
approach for the identification of SERT modulators. Further, with the development of 
ligands aiming at other pharmacologically relevant targets, our approach may potentially 
form the basis for a multi-target drug discovery platform. 
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A.2 Introduction 
Major depression occurs in 2 - 5% of the U. S. population and is the most 
common mental illness in modern society.1, 2 Depression is not only devastating, but is a 
financial burden, costing the U.S. an estimated 100 billion dollars annually.2 Selective 
serotonin reuptake inhibitors (SSRIs) that block the serotonin transporter (SERT) at 
brain synapses are, by far, the most frequently prescribed drugs for the management of 
depression.1, 3-6 A well-known major drawback of current SSRIs is their slow onset of 
antidepressant activity, requiring 3-6 weeks of administration to produce a significant 
therapeutic benefit.7 
To develop faster acting antidepressants, it was proposed that a multi-target 
strategy,7 where antagonists are designed for several pharmacologically relevant targets. 
Several studies indicate that dual-acting antidepressants such as Desvenlafaxine,8 a 
serotonin and norepinephrine reuptake inhibitor (SNRI), and SB-649915-B,9 a 5-HT1A/B 
receptor antagonist and SSRI, may provide a faster onset of antidepressant action. 
Another emerging area in antidepressant drug discovery exploits allosteric antagonists.10 
In this approach, drug candidates can be engineered to act at a site of the transporter 
distinct from the high-affinity primary binding site, consequently mediating 
conformational changes of a substrate binding pocket and attenuating neurotransmitter 
uptake. No crystal structure of any neurotransmitter transporter is presently available, 
which makes it difficult to validate the allosteric antagonism. Several high-affinity SSRIs 
have been previously proposed as allosteric modulators for SERT, including paroxetine, 
(Paxil), a high-affinity SERT-specific inhibitor and FDA-approved SSRI.11 
Recently, several new multi-target antagonists and allosteric modulators have 
shown improved efficacy and success in clinical trials. However, progress in next-
generation antidepressant drug discovery has been largely delayed by the lack of 
appropriate screening platforms.7 At present, methods used to investigate transporter 
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binding/activity rely on conventional biochemical methods such as in vitro 
phosphorylation assay, electrophysiology,12 or radio-labeled substrate uptake assay.12 
These methods are labor-intensive, time-consuming, and in the latter case, require 
isotope use. 
Alternatively, fluorescent probes can be used for target-selective drug screening. 
However, when using common fluorophores, the two major limiting features are 
photostability and sensitivity. In recent years, QDot development has achieved promising 
results that overcome the disadvantages associated with conventional 
biolabelingfluorophores.13-16 Previously, we have demonstrated the use of ligand-
conjugated QDots for visualization of SERT, GABAC receptor, and most recently, the 
dopamine transporter.17-19 In this report, we advance the ligand-conjugated QDot 
labeling approach as an antidepressant drug screening platform in single, living oocytes.  
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A.3 Experimental Section 
A.3.1 IDT318 ligand synthesis 
 The synthesis details and spectroscopic characterization have been previously 
described in our recent publications.20, 21 Brief scheme is shown in Figure 1. Initially, the 
parent drug 5-methoxy-3-(1,2,5,6-tetrahydro-4-pyridinyl)-1H-indole (1) was synthesized 
and coupled to 11-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-undecyl bromide (2) to yield 2-
(11-(4-(5-methoxy-1H-indol-3yl)-5,6-dihydropyridin-(2H)-yl)undecyl) isoindoline-1,3-dione 
(3) in the presence of triethylamine (Et3N). The phthalimide protecting group was 
removed using hydrazine monohydrate to give 11-(4-(5-methoxy-1H-indol-3-yl)-5,6-
dihydropyridin-1(2H)-yl)undecan-1- amine (4). This is then coupled to biotin-polyethylene 
glycol-N-hydroxysuccinimide ester to give the SERT ligand IDT318 (5) for the study. 
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Figure A.1 Schematic of IDT318 synthesis 
 
A.3.2 hSERT-expressing oocyte prepapation 
 Xenopus oocytes and hSERT cRNA were prepared and isolated as previously 
described.12, 22 In brief, stage V-VI oocytes were harvested from Xenopus laevis (Nasco, 
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Medesto, CA). After harvesting, the follicle cell layer was removed by incubation with 2 
mg/ml collagenase in Ringer's buffer (in mM, 96 NaCl, 2 KCl, 5 MgCl2, 5 HEPES, pH 7.4) 
for an hour. cRNA injections were performed on the day of harvest. hSERT cRNA was 
transcribed from NotI (New England BioLabs, Beverly, MA)-digested cDNA in pOTV 
vector (a gift of Dr. Mark Sonders, Columbia University) using Ambion mMessage 
Machine T7 kit (Ambion, Austin, TX). The cRNA concentrations were confirmed by UV 
spectroscopy and gel electrophoresis. Each oocyte was injected with 3 ng cRNA and 
incubated at 18 C° for 3-6 days in Ringer's buffer supplemented with 550 μM/ml sodium 
pyruvate, 100 μg/ml streptomycin, 50 μg/ml tetracycline, and 5 % dialyzed horse serum. 
Healthy oocytes for subsequent electrophysiological and fluorescence assays were 
selected by visual inspection. 
 
A.3.3 Quantum dot-hSERT labeling and displacement in oocytes 
 For two-step QDot-SERT labeling, oocytes were first incubated with 1 M 
biotinylated ligand in PBS for 60 minutes prior to 5 minutes incubation of 2.5 nM SA-
QDot (Qdot® 655 streptavidin conjugate, Invitrogen, Carlsbad, CA). 
 The pre-incubation affinity assay was demonstrated using paroxetine and 5-HT 
as testing drugs. In pre-incubation affinity assay, oocytes were first incubated with 
testing drug (1 M for paroxetine; 1 mM for 5-HT) in PBS for 60 minutes, followed by a 
ligand/drug mixture incubation (1 M/1M for paroxetine; 1 M/1 mM for 5-HT) in PBS 
for another 60 minutes, and then finally incubated with 2.5 nM SA-QDot for 5 minutes. 
After QDot labeling, single oocytes were transferred to 8-well Lab-Tek chamber slides 
(NUNC, Roskilde, Denmark) and imaged in PBS. Excess ligand, drug, and QDot were 
removed by two washes with PBS at each step.  
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 For time course displacement assay, selected single hSERT expressing oocyte 
was transferred to one well of Lab-Tek 8-well chamber slide after processing two-step 
QDot-SERT labeling, each well contain either 0 M (control), 10 M or 20 M of 
paroxetine in 400 L PBS. A time series of fluorescent images was immediately acquired 
at a 1 minute interval over a 30 minute period. 
 
A.3.4 Microscopy 
 Confocal images were obtained on a Zeiss LSM 510META confocal imaging 
system (Carl Zeiss Microimaging, Inc., Thornwood, NY). Images were collected using a 
Zeiss Plan-Apochromat 5×/0.16 numerical aperture (NA) objective lens and excited by 
an argon laser at 458 nm with 25% transmission rate and pinhole was set to 2 Airy units. 
All images were 512×512 pixels in size and had an 8-bit pixel depth. For single ligand 
labeling experiments, fluorescence signal was collected on photomultiplier-tube (PMT) 
detector after passing through a 650 nm cutoff filter to ensure the transmission of only 
the Qdot 655 signal. 
 Wide-field fluorescent images were acquired using a Zeiss Axiovert 200 M 
inverted fluorescence microscope equipped with a Photometrics Cool-SnapTM HQ2 
electrically cooled CCD camera (Intelligent Imaging Innovations, Denver, CO), a Zeiss 
Plan-Neofluar 20×/0.4 numerical aperture (NA) objective lens and QDot655 filter set (XF 
1002 filter, Omega Optical, Brattleboro, VT). Exposure time was set at 200 ms for all 
fluorescent imaging. Image acquisition and analysis was processed using Metamorph® 7 
imaging software (Molecular Devices Corp.; Downingtown, PA).  
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A.3.5 Two-electrode voltage-clamp electrophysiological analysis 
 Whole-cell currents were measured with two electrode voltage clamp techniques 
using a GeneClamp 500 (Molecular Devices, Palo Alto, CA). Microelectrodes were 
pulled using a programmable puller (Model P-87, Sutter Instrument, Novato, CA) and 
filled with 3 M KCl (0.5-5 MΩ resistance). A 16-bit A/D converter (Digidata 1322A, 
Molecular Devices) interfaced to a PC computer running Clampex 9 software (Molecular 
Devices) was used to control membrane voltage and to acquire data. To induce hSERT-
associated current, serotonin was dissolved (typically 10 μM) in a buffer solution (in mM, 
120 NaCl, 5.4 potassium gluconate, 1.2 calcium gluconate, 7.2 HEPES, pH 7.4) and 
applied to oocytes using a gravity-flow perfusion system (4-5 ml/min flow rate). 
Serotonin-induced current is defined by subtraction of current in the presence of 
serotonin from current in the absence of serotonin. For recordings, data were low-pass 
filtered at 10 Hz and digitized at 20 Hz. Analyses were performed using Origin 7 (Origin 
Lab, Northampton, MA). 
 
A.3.6 Data Analysis 
 For displacement assays, each time-series of wide-field fluorescence images 
was analyzed using Metamorph’s active region measurement program. Briefly, an initial 
active region was selected from the membrane halo region of the fluorescent image, and 
this same region was applied to each fluorescence image for subsequent time flame. 
The correlation of background signal was performed by subtracting the result from the 
background image on a pixel-by-pixel basis. Background signal of the CCD detector was 
measured by taking the fluorescence image under the same experimental setup without 
sample loading. Data were measured as relative fluorescent units (RFUs) and 
normalized to the following equation: 
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0
tFnormalized response
F
  [1] 
, where Ft is the fluorescent signal generated in the presence of paroxetine at time t; F0 
is the initial fluorescent intensity generated in the absence of paroxetine. 
 Data were evaluated by fitting to either a linear or single exponential equation for 
control experiment and Paroxetine displacing experiment, respectively. For the control 
experiment, each time course data points were fit into a linear curve regression equation: 
0 0
tF F A t
F F
    [2] 
, where Ft is the fluorescent signal generated in the presence of paroxetine at time t; F0 
is the initial fluorescent intensity generated in the absence of paroxetine, F∞ is the 
fluorescent intensity at infinite time, and A represents amplitude. For the paroxetine 
displacing experiment, the time courses were fit into a single-exponential equation: 
0 0
appk ttF F B e
F F
     [3] 
, where Ft is the fluorescent signal generated in the presence of paroxetine at time t; F0, 
the initial fluorescent intensity generated in the absence of paroxetine; F∞, the 
fluorescent intensity at infinite time; kapp, the apparent rate constant; B, the amplitude. All 
the fitting curves were generated by using SigmaplotTM software (Version 11.2, Systat 
Software Inc., San Jose, CA).  
 Measurements of each reaction kinetics for QDot-based displacement assays 
were performed by taking the natural logarithm of each time courses fluorescent data 
point generated from the paroxetine displacing experiments and then plotted as a 
function of time. First-order dissociation was evaluated by fitting the 0-10minute data 
points to the linear curve regression using Sigmaplot software. 
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 Note that the SA-QDots we used in this study have potentially 4-10 
streptavidins/QDot, suggesting a possible 16-40 binding sites/QDot.23 A recent study 
reported that this particular kind of SA-QDots has ~5 biotin binding sites/QDot.24 As can 
be seen in Fig. 3B, the dissociation of QDot-ligand from hSERT proteins can be 
categorized into roughly two stages where the first 10 minutes seems significantly faster. 
Further analysis in Fig. 3C indicated that a plot of ln(Ft/F0) as a function of time at the 
initial 10 minutes appear to be linear, a character of first-order dissociation, suggesting 
the binding valency is monovalent. As illustrated in the figure 5, we recognize that it is 
possible that the displacement in our platform may be indicative of a two-stage 
dissociation process in which the initial monovalent dissociation is followed by a 
multivalent dissociation. A solution to resolve this issue is to introduce the monovalent 
streptavidin conjugated QDots developed by Ting and coworkers.23 
 
 
 
 
Figure A.2 Schematic of putative two-stage ligand-SERT dissociation mechanism of 
QDot-labeled ligand-SERT complexes in the oocyte expression system 
  
Step 2: “Slow” process: 
Multivalentdissociation 
Step 1: “Fast” process 
(initial 10 mins): 
Monovalentdissociation
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A.4 Results 
Figure A.3 illustrates two modes by which ligand-conjugated QDot displacement 
can occur. The first mode is by preventing the ligand re-association with the primary 
(orthosteric) binding site (left); and the second mode is through an allosteric mechanism 
that shifts the primary binding site conformation, dissociating the ligand (right).  
 
 
Figure A.3 Fluorescence displacement assay based on ligand-conjugated QDots for 
antidepressant drug discovery. Target proteins (transporters or receptors) bind to the 
QDot-tagged ligands, forming complexes that increase fluorescent signal along the 
membrane. When exposed to a potential drug which competes with the binding (left) or 
induces a conformational change in the binding site (right), the QDot-tagged ligands are 
displaced resulting in a decrease in fluorescence intensity. The blue shadow area 
indicates the imaging focal plane while processing the assay. 
 
The structure of the IDT318 ligand used in this study is depicted in Figure A.4A. 
The synthesis details have been previously described.20, 21 As indicated, IDT318 ligand is 
composed of four components. Ligand design was based on comprehensive screening 
of trypamine derivatives.25 5-methoxy-3-(1,2,5,6-tetrahydro-4-pyridinyl)-1H-indole 
(RU24969), which retains the tryptamine moiety for a putative common 5-HT binding site 
and features enhanced selectivity for human serotonin transporter (hSERT),25 is readily 
adapted as a tethered ligand for hSERT binding26 (component I). The alkyl spacer 
serves to enhance the ligand binding through the interaction of the hydrophobic residues 
in the transmembrane domains of membrane channels or transporters (component II, 
see also Figure A.5B). The polyethylene glycol (PEG) chain is used to increase water 
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To visualize the hSERT distribution in our oocyte model, a two-step labeling 
approach was implemented in which a hSERT-expressing oocyte was incubated with 
IDT318 followed by incubation with SA-QDots. As shown in Figure A.4B (Column 1), the 
QDot fluorescence forms a sharp halo correlating to the membrane of the hSERT 
expressing oocyte, whereas incubation with non-expressing control oocyte shows no 
sign of labeling (Column 2). Ligand binding specificity was demonstrated using a QDot-
based pre-incubation affinity assay where the hSERT-expressing oocyte is pre-
incubated with paroxetine prior to the two-step QDot labeling. As can be seen in Column 
3, paroxetine effectively blocked the QDot labeling, demonstrating the binding specificity 
of IDT318 to hSERT. In comparison, preincubation of a hSERT-expressing oocyte with 
0.1 mM 5-HT prior to the two-step QDot labeling only shows reduced QDot fluorescence 
intensity (Column 4). This reduced QDot labeling could be the result of incomplete 
saturation of hSERT binding with 5-HT; however, this is unlikely since the 5-HT 
concentration was 120 times greater than the reported Ki value against hSERT.25 A more 
likely explanation is the reversible binding mode, in which IDT318 competes with 5-HT 
for the primary binding site. This rationale is also consistent with our previous finding 
indicating that tryptamine analogs including RU24969 shares, a common substrate 
binding site at hSERT.25 Importantly, the influence of IDT318 on hSERT activity was 
further characterized with an oocyte electrophysiological assay (Figure A.5A), indicating 
the role of IDT318 as a hSERT antagonist. 
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Figure A.5 (A) Current response induced by IDT318 ligand incubation. Figure shown 
here is a representative recording from a single hSERT expressing oocyte voltage-
clamped at -60 mV. The leakage current profile after incubating with IDT318 displays a 
typical SERT antagonist behavior.29 (5HT: 5-Hydroxytryptamine, serotonin) (B) 
Comparison of current responses with QD labeling results for the indication of alkyl 
space participated in ligand binding. We recently published the current responses of the 
IDT318 and its structure-related ligands (left scale) using hSERT expression oocytes. 
Here we compared the current responses with QD labeling results (right scale). As can 
be seen, results generated by both methods show a similar trend as the length of alkyl 
spacer increases. However, the QD labeling result shows higher sensitivity as evident by 
a smaller standard deviation. (Fluorescent results: n = 6 oocytes/group; Current results: 
n = 4 oocytes/group) 
 
The potential utility of our labeling model for SSRI screening was explored 
utilizing paroxetine. In order for the drug candidate to rapidly displace the fluorophore-
tagged ligand at a reasonable drug concentration, a ligand with an affinity in the µM 
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range is required.30 As indicated in Figure A.6, the IDT318 shows the desired µM affinity. 
In our displacement assay, a 30 minute time-course imaging at 1 minute intervals was 
carried out immediately after paroxetine incubation. QDotfluorescence intensity was 
measured and normalized to Ft / F0, where F0 is the initial fluorescent signal and theFt is 
the fluorescent signal at time t. Representative time-lapse fluorescent images and 
fluorescence intensity traces are shown in Figure A.7A and A.7B, respectively. Time- 
and concentration-dependent fluorescenceintensity reduction is apparent in the 
presence of paroxetine. In contrast, when using 5-HT as the displacing drug, the 
dramatic QDot fluorescent reduction as seen with paroxetine treatment vanished (Figure 
A.8). Note that there was less than a 10 % reduction in fluorescence intensity observed 
after 30 minutes of buffer incubation (Figure A.7B), indicating that the effect of QDot 
quenching and spontaneous ligand dissociation minimally contributes to the results. 
Furthermore, the log plot of Ft / F0 as a function of time is linear in the first 10 minutes, 
indicating first-order dissociation kinetics (Figure A.7C). Analysis of the 10 M paroxetine 
displacement trace yields an apparent dissociation rate constant of kapp = (5.0  0.4) 10-
4 s-1. Doubling the paroxetine concentration results in a nearly proportional increase in 
kapp = (1.08  0.05) 10-3 s-1 (see methods for fitting details). Hence, this displacement 
platform exhibits necessary sensitivity for SSRI screening. Importantly, the dissociation 
kinetics shown in FigureA.7C indicate that the time-series displacement can be 
performed in less than 10 minutes. From a technological perspective, the throughput of 
our QDot-based displacement assays can be increased more than 100 fold if used with 
a commercially available automated multiwell plate high throughput screening imaging 
system. 
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Figure A.6 IC50 measurement of IDT318 ligand. The ability of IDT318 to inhibit the 
uptake of serotonin was measured by incubating hSERT expressing oocytes in the 
presence of 50 nM tritiated serotonin and increasing concentrations of IDT318. The 
accumulated radioactivity was plotted against concentration of IDT318. The IC50 of 
IDT318 was found to be 3.4 ± 1.4 μM (mean ± SD).  
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Figure A.8 Displacement of the IDT318 conjugated QD with 10 M paroxetine and 5-HT. 
Results are representative micrographs from at least 3 independent experiments. 
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A.5 Discussion 
 The ability of paroxetine to displace IDT318 at SERT is most likely to be a non-
competitive, allosteric modeof interaction of the antidepressant with the transporter, as 
opposed to a simple competition for an orthosteric binding site.11, 31Recently, it was 
shown that mutations at the major antidepressant binding site of SERT do not impact 
paroxetine,also suggesting a non-competitive mode of interaction.26Additionally, non-
competitive dissociation of ligands from binding sites is expected to follow first-order 
dissociation kinetics, as in the case of S-citalopram,32, 33an SSRI frequently proposed to 
interact with SERT via an allosteric mechanism. 
In conclusion, we have demostrated a fluorescence displacement assay for 
antidepressant drug discovery based on ligand conjugated QDots. Furthermore, our 
method is the first target-selective drug discovery platform that utilizes fluorescent QDots. 
This system may aid in mapping allosteric mechanisms of SERT modulation and 
potentially form the basis for a multi-target drug discovery platform employing ligand-
conjugated QDots that selectively bind to other pharmacologically relevant proteins, 
such as dopamine transporter19 and norepinephrine transporter. Ultimately, this platform 
may provide more insight into the effects of different structural features on the binding 
kinetics of any ligand-protein interaction and therefore serve as a generalized approach 
for the development of drugs beyond antidepressants. 
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